<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>RASA2 - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .status-badge {
            padding: 0.375rem 0.875rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .status-initialized {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fde68a;
        }

        .status-in-progress {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #bfdbfe;
        }

        .status-draft {
            background-color: #fce7f3;
            color: #831843;
            border: 1px solid #fbcfe8;
        }

        .status-complete {
            background-color: #d1fae5;
            color: #065f46;
            border: 1px solid #a7f3d0;
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ‚ñº';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ‚ñ∫';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>RASA2</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/Q15283" target="_blank" class="term-link">
                        Q15283
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Review Status:</span>
                <span class="status-badge status-complete">
                    COMPLETE
                </span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Aliases:</span>
                <div class="aliases">
                    
                    <span class="badge">RAS p21 protein activator 2</span>
                    
                    <span class="badge">GAP1(m)</span>
                    
                    <span class="badge">GAP1 family member 2</span>
                    
                </div>
            </div>
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                üìù Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "RASA2";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="Q15283" data-a="DESCRIPTION: RAS p21 protein activator 2, GTPase-activating pro..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">üëç</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">üëé</button>
            </span>
        </div>
        <p>RAS p21 protein activator 2, GTPase-activating protein (GAP) for RAS family small GTPases. Member of GAP1 family of RasGAPs characterized by tandem C2 domains (Ca2+ and phospholipid binding), pleckstrin homology (PH) domain (binds PIP3 with high affinity), and C-terminal RasGAP catalytic domain. Functions as tumor suppressor by negatively regulating RAS signaling: catalyzes GTP hydrolysis on RAS proteins (HRAS, KRAS, NRAS, R-Ras) via arginine-finger mechanism (Arg-511), converting active RAS-GTP to inactive RAS-GDP. Cytoplasmic protein with regulated membrane association - PH domain recruitment to PIP3-enriched membranes brings RASA2 to sites of active RAS signaling. Loss of RASA2 leads to hyperactive RAS-MAPK and RAS-PI3K pathways, promoting cell proliferation, survival, and tumorigenesis. Recurrent inactivating mutations identified in ~5% of melanomas; loss associated with enhanced ERK signaling, increased proliferation/migration, and worse patient outcomes. Rare germline mutations cause Noonan syndrome (Rasopathy) due to elevated developmental RAS activity. In T cells, RASA2 acts as brake on TCR signaling - RASA2-deficient T cells show ~2-fold increased proliferation, enhanced activation markers (CD69, CD154), heightened antigen sensitivity, and improved tumor cell killing. Expression in immune cells, endothelium, and various tissues. Part of negative feedback mechanisms restraining growth factor receptor signaling cascades.</p>
    </div>
    

    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005096" target="_blank" class="term-link">
                                    GO:0005096
                                </a>
                            </span>
                            <span class="term-label">GTPase activator activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q15283" data-a="GO:0005096" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> RASA2/GAP1m is a Ras GTPase-activating protein that accelerates hydrolysis of Ras-GTP to Ras-GDP, thereby downregulating RAS output. This is the core molecular function of the protein, supported by phylogenetic inference and extensive literature.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core enzymatic function of RASA2. The protein contains a conserved RasGAP catalytic domain with an arginine finger residue (Arg-397 in human) that is essential for stimulating GTP hydrolysis. This function is well-established across the GAP1 family of RasGAPs.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/8812506" target="_blank" class="term-link">
                                        PMID:8812506
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">We have previously isolated a novel Ras GTPase-activating protein (Ras GAP), Gap1m, from rat brain. Gap1m is considered to be a negative regulator of the Ras signaling pathways, like other Ras GAPs, neurofibromin, which is a gene product of the neurofibromatosis type I gene, and p120GAP.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    Reactome:R-HSA-5658435
                                    
                                </span>
                                
                                <div class="support-text">GAP proteins stimulate RAS GTPase activity by inserting a conserved arginine residue into the RAS active site, promoting a conformational change in the active site to allow GTP hydrolysis (Ahamdian et al, 2003; Scheffzek et al, 1997; Ahamdian et al, 1997).</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/RASA2/RASA2-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">See deep research file for comprehensive analysis</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1902531" target="_blank" class="term-link">
                                    GO:1902531
                                </a>
                            </span>
                            <span class="term-label">regulation of intracellular signal transduction</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q15283" data-a="GO:1902531" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> RASA2 regulates intracellular signal transduction by negatively regulating the RAS-RAF-MEK-ERK cascade and RAS-PI3K signaling. Loss of RASA2 leads to hyperactive MAPK signaling.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core regulatory function. RASA2 functions as an intracellular checkpoint that limits RAS/MAPK signaling. In T cells, RASA2 deficiency results in enhanced MAPK signaling and increased T cell activation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/RASA2/RASA2-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">RASA2 negatively regulates the RAS-RAF-MEK-ERK cascade by accelerating Ras GTP hydrolysis; its lipid-binding domains coordinate membrane recruitment, ensuring spatial coupling of Ras inactivation with effector engagement.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005096" target="_blank" class="term-link">
                                    GO:0005096
                                </a>
                            </span>
                            <span class="term-label">GTPase activator activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q15283" data-a="GO:0005096" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Automated annotation of GTPase activator activity based on combined computational evidence. Consistent with the experimentally validated RasGAP function of RASA2.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core enzymatic function. Duplicates the IBA annotation with computational evidence, which is consistent with the known function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/RASA2/RASA2-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">Inhibitory regulator of the Ras-cyclic AMP pathway.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005543" target="_blank" class="term-link">
                                    GO:0005543
                                </a>
                            </span>
                            <span class="term-label">phospholipid binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q15283" data-a="GO:0005543" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> RASA2 contains PH and C2 domains that bind membrane phospholipids. The PH domain binds PIP3 with high affinity, and the tandem C2 domains bind calcium and phospholipids for membrane targeting.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Important accessory function for membrane localization. The PH domain enables recruitment to PIP3-enriched membranes where active RAS signaling occurs. The C2 domains provide additional lipid-binding capacity.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/RASA2/RASA2-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">PH and C2 domains confer lipid-dependent membrane association of RasGAPs, coordinating with the catalytic domain to accelerate Ras GTP hydrolysis at the plasma membrane/inner leaflet signalling sites.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/RASA2/RASA2-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">Binds inositol tetrakisphosphate (IP4).</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005737" target="_blank" class="term-link">
                                    GO:0005737
                                </a>
                            </span>
                            <span class="term-label">cytoplasm</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q15283" data-a="GO:0005737" data-r="GO_REF:0000044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> RASA2 is a cytoplasmic protein with regulated membrane association. It is recruited to the plasma membrane via PH domain binding to PIP3 upon growth factor stimulation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core localization. UniProt explicitly states cytoplasmic localization. The cytoplasmic pool is recruited to membranes in response to signaling.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/RASA2/RASA2-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, perinuclear region.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0008270" target="_blank" class="term-link">
                                    GO:0008270
                                </a>
                            </span>
                            <span class="term-label">zinc ion binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q15283" data-a="GO:0008270" data-r="GO_REF:0000043" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> RASA2 contains a Btk-type zinc finger domain (residues 708-744) with four conserved cysteine residues (Cys-716, Cys-727, Cys-728, Cys-738) that coordinate a zinc ion.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Structural requirement for protein stability. The Btk-type zinc finger is a conserved structural element in the GAP1 family.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/RASA2/RASA2-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">ZN_FING 708..744 /note=&#34;Btk-type&#34;</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0035556" target="_blank" class="term-link">
                                    GO:0035556
                                </a>
                            </span>
                            <span class="term-label">intracellular signal transduction</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q15283" data-a="GO:0035556" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> RASA2 participates in intracellular signal transduction as a negative regulator of RAS signaling pathways, including RAS-MAPK and RAS-PI3K cascades.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function in signal transduction. RASA2 terminates RAS signaling by catalyzing GTP hydrolysis, which is a fundamental intracellular signaling mechanism.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/8699317" target="_blank" class="term-link">
                                        PMID:8699317
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Ras, ras gene product, is a GTP binding protein which controls the signal transduction by GTP hydrolysis.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0046580" target="_blank" class="term-link">
                                    GO:0046580
                                </a>
                            </span>
                            <span class="term-label">negative regulation of Ras protein signal transduction</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q15283" data-a="GO:0046580" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> RASA2 is a bona fide negative regulator of Ras signaling, converting active RAS-GTP to inactive RAS-GDP. This is the primary biological function of the protein.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core biological process. This term accurately captures the primary regulatory role of RASA2 in attenuating RAS signaling cascades.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/8812506" target="_blank" class="term-link">
                                        PMID:8812506
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Gap1m is considered to be a negative regulator of the Ras signaling pathways, like other Ras GAPs, neurofibromin, which is a gene product of the neurofibromatosis type I gene, and p120GAP.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    Reactome:R-HSA-5658435
                                    
                                </span>
                                
                                <div class="support-text">The human genome encodes at least 10 proteins that bind RAS and activate its intrinsic GTPase activity, resulting in the formation of inactive RAS:GDP and attenuating RAS signaling (reviewed in King et al, 2013).</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0046872" target="_blank" class="term-link">
                                    GO:0046872
                                </a>
                            </span>
                            <span class="term-label">metal ion binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q15283" data-a="GO:0046872" data-r="GO_REF:0000043" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> RASA2 binds zinc ions via its Btk-type zinc finger domain. This is a more general term than GO:0008270 (zinc ion binding).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Redundant with the more specific zinc ion binding annotation. The metal ion binding is structural rather than catalytic.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/RASA2/RASA2-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">ZN_FING 708..744 /note=&#34;Btk-type&#34; with BINDING sites for Zn(2+) at residues 716, 727, 728, 738.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0048471" target="_blank" class="term-link">
                                    GO:0048471
                                </a>
                            </span>
                            <span class="term-label">perinuclear region of cytoplasm</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q15283" data-a="GO:0048471" data-r="GO_REF:0000044" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> RASA2 localizes to the perinuclear region of the cytoplasm according to UniProt annotation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This represents a specific sublocalization within the cytoplasm. While valid, this may represent a steady-state localization rather than the functional site (plasma membrane upon recruitment).
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/RASA2/RASA2-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, perinuclear region.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/33961781" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:33961781
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Dual proteome-scale networks reveal cell-specific remodeling...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q15283" data-a="GO:0005515" data-r="PMID:33961781" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> RASA2 was identified in protein interaction studies (BioPlex 3.0). The term protein binding is uninformative as it does not specify the binding partner or functional consequence.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Protein binding is too generic. RASA2 specifically binds RAS proteins (its substrates), and has been shown to interact with NOLC1 and potentially p53. A more informative term would be GTPase binding or Ras GTPase binding.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0017016" target="_blank" class="term-link">
                                    Ras GTPase binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/33961781" target="_blank" class="term-link">
                                        PMID:33961781
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Through affinity-purification mass spectrometry, we have created two proteome-scale, cell-line-specific interaction networks.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/RASA2/RASA2-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">Q15283; Q14978: NOLC1; NbExp=2</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005829" target="_blank" class="term-link">
                                    GO:0005829
                                </a>
                            </span>
                            <span class="term-label">cytosol</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-5658231
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q15283" data-a="GO:0005829" data-r="Reactome:R-HSA-5658231" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> RASA2 is localized in the cytosol and is recruited to membranes to stimulate RAS GTPase activity. Reactome pathway includes RASA2 as a cytosolic GAP.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Consistent with UniProt annotation of cytoplasmic localization. The cytosol represents the soluble pool of RASA2 before membrane recruitment.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    Reactome:R-HSA-5658231
                                    
                                </span>
                                
                                <div class="support-text">The intrinsic GTPase activity of RAS proteins is stimulated by the GAP proteins, of which there are at least 10 in the human genome (reviewed in King et al, 2013).</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005829" target="_blank" class="term-link">
                                    GO:0005829
                                </a>
                            </span>
                            <span class="term-label">cytosol</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-5658435
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q15283" data-a="GO:0005829" data-r="Reactome:R-HSA-5658435" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Duplicate cytosol annotation from Reactome pathway describing RAS GAP binding to RAS-GTP.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Consistent localization annotation. RASA2 is a cytosolic protein that is recruited to membranes where RAS is tethered.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    Reactome:R-HSA-5658435
                                    
                                </span>
                                
                                <div class="support-text">These identified RAS GAP proteins are RASA1 (also known as p120 GAP), NF1, the GAP1 family (RASA2, RASA3, RASA4 and RASAL1) and the SYNGAP family (SYNGAP1, DAB2IP, RASAL2 and RASAL3).</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005096" target="_blank" class="term-link">
                                    GO:0005096
                                </a>
                            </span>
                            <span class="term-label">GTPase activator activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/8812506" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:8812506
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    cDNA cloning and chromosomal mapping of a novel human GAP (G...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q15283" data-a="GO:0005096" data-r="PMID:8812506" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Original cloning paper for human GAP1M/RASA2 establishing it as a novel Ras GTPase-activating protein distinct from p120GAP and NF1.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core enzymatic function established in the original characterization of human RASA2. The paper identifies GAP1M as a novel Ras GAP.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/8812506" target="_blank" class="term-link">
                                        PMID:8812506
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">We have previously isolated a novel Ras GTPase-activating protein (Ras GAP), Gap1m, from rat brain.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0007165" target="_blank" class="term-link">
                                    GO:0007165
                                </a>
                            </span>
                            <span class="term-label">signal transduction</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/8699317" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:8699317
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    [Heterogeneity of GTPase-activating proteins for Ras in the ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q15283" data-a="GO:0007165" data-r="PMID:8699317" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Review paper describing the heterogeneity of Ras GAPs and their roles in regulating Ras signal transduction, including Gap1m (RASA2).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> RASA2 participates in signal transduction by negatively regulating the Ras signaling pathway. This is a general but accurate process annotation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/8699317" target="_blank" class="term-link">
                                        PMID:8699317
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The proto-oncogene ras is an essential gene for the growth and the differentiation for various types of cells. Ras, ras gene product, is a GTP binding protein which controls the signal transduction by GTP hydrolysis.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0007165" target="_blank" class="term-link">
                                    GO:0007165
                                </a>
                            </span>
                            <span class="term-label">signal transduction</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/8812506" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:8812506
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    cDNA cloning and chromosomal mapping of a novel human GAP (G...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q15283" data-a="GO:0007165" data-r="PMID:8812506" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Duplicate signal transduction annotation based on the original cloning paper.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Valid annotation. RASA2 functions in signal transduction as a negative regulator of the Ras pathway.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/8812506" target="_blank" class="term-link">
                                        PMID:8812506
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Gap1m is considered to be a negative regulator of the Ras signaling pathways, like other Ras GAPs, neurofibromin, which is a gene product of the neurofibromatosis type I gene, and p120GAP.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>RasGAP that catalyzes GTP hydrolysis on RAS proteins (HRAS, KRAS, NRAS, R-Ras), converting active RAS-GTP to inactive RAS-GDP. Negatively regulates RAS-MAPK and RAS-PI3K signaling. Functions as tumor suppressor. PH domain binds PIP3 for membrane recruitment to sites of RAS activation.</h3>
                <span class="vote-buttons" data-g="Q15283" data-a="FUNCTION: RasGAP that catalyzes GTP hydrolysis on RAS protei..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005096" target="_blank" class="term-link">
                            GTPase activator activity
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0046580" target="_blank" class="term-link">
                                negative regulation of Ras protein signal transduction
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1902531" target="_blank" class="term-link">
                                regulation of intracellular signal transduction
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005737" target="_blank" class="term-link">
                                cytoplasm
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005829" target="_blank" class="term-link">
                                cytosol
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/RASA2/RASA2-uniprot.txt
                            
                        </span>
                        
                        <div class="finding-text">Inhibitory regulator of the Ras-cyclic AMP pathway.</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/8812506" target="_blank" class="term-link">
                                PMID:8812506
                            </a>
                            
                        </span>
                        
                        <div class="finding-text">We have previously isolated a novel Ras GTPase-activating protein (Ras GAP), Gap1m, from rat brain.</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000002.md" target="_blank" class="term-link">
                            GO_REF:0000002
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation through association of InterPro records with GO terms.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000033.md" target="_blank" class="term-link">
                            GO_REF:0000033
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Annotation inferences using phylogenetic trees</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000043.md" target="_blank" class="term-link">
                            GO_REF:0000043
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000044.md" target="_blank" class="term-link">
                            GO_REF:0000044
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000120.md" target="_blank" class="term-link">
                            GO_REF:0000120
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Combined Automated Annotation using Multiple IEA Methods.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/33961781" target="_blank" class="term-link">
                            PMID:33961781
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/8699317" target="_blank" class="term-link">
                            PMID:8699317
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">[Heterogeneity of GTPase-activating proteins for Ras in the regulation of Ras signal transduction pathway].</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/8812506" target="_blank" class="term-link">
                            PMID:8812506
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">cDNA cloning and chromosomal mapping of a novel human GAP (GAP1M), a GTPase-activating protein of Ras.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-5658231
                        
                    </span>
                </div>
                
                <div class="reference-title">RAS GAPs stimulate RAS GTPase activity</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-5658435
                        
                    </span>
                </div>
                
                <div class="reference-title">RAS GAPs bind RAS:GTP</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/RASA2/RASA2-deep-research-openai.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Deep research on RASA2 function</div>
                
                
            </div>
            
        </div>
    </div>
    


    

    

    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">üìö Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Falcon</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(RASA2-deep-research-falcon.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q15283" data-a="DOC: Deep Research Falcon" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: falcon<br />
model: Edison Scientific Literature<br />
cached: false<br />
start_time: '2025-12-14T17:16:09.886749'<br />
end_time: '2025-12-14T17:23:06.940731'<br />
duration_seconds: 417.05<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: RASA2<br />
  gene_symbol: RASA2<br />
  uniprot_accession: Q15283<br />
  protein_description: 'RecName: Full=Ras GTPase-activating protein 2; AltName: Full=GTPase-activating<br />
    protein 1m; Short=GAP1m;'<br />
  gene_info: Name=RASA2; Synonyms=GAP1M, RASGAP;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Not specified in UniProt<br />
  protein_domains: C2_dom. (IPR000008); C2_domain_sf. (IPR035892); PH-like_dom_sf.<br />
    (IPR011993); PH_domain. (IPR001849); Ras_GTPase. (IPR039360)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
citation_count: 34</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q15283</li>
<li><strong>Protein Description:</strong> RecName: Full=Ras GTPase-activating protein 2; AltName: Full=GTPase-activating protein 1m; Short=GAP1m;</li>
<li><strong>Gene Information:</strong> Name=RASA2; Synonyms=GAP1M, RASGAP;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> C2_dom. (IPR000008); C2_domain_sf. (IPR035892); PH-like_dom_sf. (IPR011993); PH_domain. (IPR001849); Ras_GTPase. (IPR039360)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "RASA2" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'RASA2' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>RASA2</strong> (gene ID: RASA2, UniProt: Q15283) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p>Question: You are an expert researcher providing comprehensive, well-cited information.</p>
<p>Provide detailed information focusing on:<br />
1. Key concepts and definitions with current understanding<br />
2. Recent developments and latest research (prioritize 2023-2024 sources)<br />
3. Current applications and real-world implementations<br />
4. Expert opinions and analysis from authoritative sources<br />
5. Relevant statistics and data from recent studies</p>
<p>Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.<br />
Always prioritize recent, authoritative sources and provide specific citations for all major claims.</p>
<h1 id="gene-research-for-functional-annotation_1">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context_1">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot_1">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q15283</li>
<li><strong>Protein Description:</strong> RecName: Full=Ras GTPase-activating protein 2; AltName: Full=GTPase-activating protein 1m; Short=GAP1m;</li>
<li><strong>Gene Information:</strong> Name=RASA2; Synonyms=GAP1M, RASGAP;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> C2_dom. (IPR000008); C2_domain_sf. (IPR035892); PH-like_dom_sf. (IPR011993); PH_domain. (IPR001849); Ras_GTPase. (IPR039360)</li>
</ul>
<h3 id="mandatory-verification-steps_1">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "RASA2" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature_1">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'RASA2' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target_1">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>RASA2</strong> (gene ID: RASA2, UniProt: Q15283) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<p>Plan and verification<br />
- Target identity: We focus on human RASA2 (UniProt Q15283), also known as GAP1m/GTPase-activating protein 1m. Literature classifies GAP1m/RASA2 among Ras-specific GAPs with a RasGAP catalytic domain and membrane-targeting/regulatory modules including C2 and PH domains, consistent with the UniProt-provided domain set (PH-like, PH, C2, RasGTPase/GAP) (scheffzek2019; conserved C2‚ÄìGAP architecture augmenting catalytic function across RasGAPs) (scheffzek2019rasspecificgtpaseactivatingproteinsstructures pages 12-14, paul2025thec2domain pages 4-6).</p>
<p>Key concepts and definitions<br />
- Molecular function: RASA2 is a Ras GTPase-activating protein (RasGAP) that accelerates hydrolysis of Ras-GTP to Ras-GDP, thereby downregulating RAS output (e.g., RAF‚ÄìMEK‚ÄìERK) in response to membrane signals. In T cells, RASA2 functions as an intracellular checkpoint that limits RAS/MAPK signalling upon antigen stimulation (Nature 2022) (https://doi.org/10.1038/s41586-022-05126-w; Aug 2022) (carnevale2022rasa2ablationin pages 1-2).<br />
- Domains and mechanism: RasGAP family members, including GAP1m/RASA2, possess a catalytic RasGAP module and adjacent regulatory lipid-binding modules (C2 and PH) that help target and regulate activity at membranes. Recent structural work shows GAP-proximal C2 surfaces augment GAP catalytic activity; this architecture is conserved across C2-containing RasGAPs and underpins physiological regulation of Ras hydrolysis (https://doi.org/10.1073/pnas.2418433122; Feb 2025). Broader reviews detail RasGAP modular organization and mechanism (https://doi.org/10.1101/cshperspect.a031500; Aug 2019) (paul2025thec2domain pages 4-6, scheffzek2019rasspecificgtpaseactivatingproteinsstructures pages 12-14).<br />
- Substrate specificity: RASA2 is a Ras-specific GAP acting on the classical RAS isoforms to terminate RAS-GTP signalling; reviews of RAS‚Äìeffector competition and GAP control detail how GAP activity influences effector engagement (e.g., RAF, PI3K) and localization (https://doi.org/10.1016/j.molcel.2024.06.027; Aug 2024; https://doi.org/10.3390/kinasesphosphatases1020007; Apr 2023) (mozzarelli2024functionalandstructural pages 6-7, nair2023regulationofrasgtpase pages 10-12).<br />
- Cellular/localization context: PH and C2 domains confer lipid-dependent membrane association of RasGAPs, coordinating with the catalytic domain to accelerate Ras GTP hydrolysis at the plasma membrane/inner leaflet signalling sites (scheffzek2019; Paul 2025) (scheffzek2019rasspecificgtpaseactivatingproteinsstructures pages 12-14, paul2025thec2domain pages 4-6).</p>
<p>Recent developments (prioritized 2023‚Äì2024)<br />
- Melanoma genomics: In a real-world targeted DNA sequencing cohort of 254 cutaneous melanomas (2013‚Äì2023), RASA2 was recurrently altered (n=22; 8.7%), and NF1 mutations significantly co-occurred with RASA2 loss (Pearson r=0.37, adjusted p&lt;0.001), supporting a tumor-suppressor role within MAPK pathway regulation and alignment with historic reports of RASA2 inactivation in melanoma (https://doi.org/10.3390/cancers16071347; Jan 2024; review context https://doi.org/10.3390/cancers12103066; Oct 2020) (haugh2024targeteddnasequencing pages 7-9, bellazzo2020cuttingthebrakes pages 15-17).<br />
- Somatic SVs in melanoma: A harmonized analysis of melanoma structural variants (JCI 2024) highlighted recurrent pathway regulators including SPRED1 and RASA2 in certain subtypes, reinforcing the broader theme of Ras pathway negative regulators in melanoma; though details vary by subtype, the study supports biologic/therapeutic impact of noncanonical drivers (https://doi.org/10.1172/jci177270; May 2024) (haugh2024targeteddnasequencing pages 7-9).<br />
- Radioresistance in NSCLC: A 2024 translational study linked high RASA2 to decreased radiotherapy response in NSCLC, proposing a mechanism whereby RASA2 binds p53, promotes its phosphorylation and ubiquitin‚Äìproteasome degradation, and thereby reduces apoptosis after irradiation (https://doi.org/10.21037/tlcr-24-160; Mar 2024) (li2024theroleof pages 1-3).<br />
- RAS signalling context: A 2024 Molecular Cell review synthesizes how RAS‚Äìeffector interactions and GAP-mediated inactivation shape pathway flux and localization, providing mechanistic context for how RASA2 loss elevates RAS-GTP and biases effector engagement (https://doi.org/10.1016/j.molcel.2024.06.027; Aug 2024). A 2023 review summarizes post-translational regulation of RAS and the roles of GAPs/GEFs in oncogenic signalling (https://doi.org/10.3390/kinasesphosphatases1020007; Apr 2023) (mozzarelli2024functionalandstructural pages 6-7, nair2023regulationofrasgtpase pages 10-12).</p>
<p>Current applications and implementations<br />
- Engineered T cells/CAR-T (gene editing): Multiple screens and preclinical studies identify RASA2 as an intracellular checkpoint whose knockout enhances MAPK signalling, antigen sensitivity, cytolytic function, metabolic fitness, and persistence of engineered human T cells. The Nature 2022 study demonstrated improved tumor control across leukemia and solid tumor xenografts, with RASA2-KO CAR T cells outcompeting controls in bone marrow and conferring prolonged survival (https://doi.org/10.1038/s41586-022-05126-w; Aug 2022) (carnevale2022rasa2ablationin pages 8-9, carnevale2022rasa2ablationin pages 7-8).<br />
- 2024 implementation reviews: Reviews in Biomarker Research (May 2024) and Leukemia (Oct 2024) summarize the use of CRISPR and base-editing to optimize CAR-T, explicitly noting RASA2 as a screen-derived intracellular checkpoint target for enhancing engineered T cell function and discussing manufacturing/delivery approaches (https://doi.org/10.1186/s40364-024-00602-z; https://doi.org/10.1038/s41375-024-02444-y) (song2024crisprcasbasedcartcells pages 7-9, lei2024leveragingcrisprgene pages 20-21).</p>
<p>Expert opinions and analysis<br />
- Mechanistic positioning: Expert reviews (Cold Spring Harbor Perspectives in Medicine 2019; Molecular Cell 2024) emphasize that RasGAPs are modular, with lipid-binding domains (C2/PH) guiding subcellular targeting and augmenting catalysis, consistent with RASA2‚Äôs predicted architecture. The 2025 PNAS study provides direct evidence that the GAP-proximal C2 surface is functionally required to augment catalytic activity across RasGAPs, supporting the inference that RASA2‚Äôs C2 domain is critical for its physiological Ras inactivation role (https://doi.org/10.1101/cshperspect.a031500; https://doi.org/10.1016/j.molcel.2024.06.027; https://doi.org/10.1073/pnas.2418433122) (scheffzek2019rasspecificgtpaseactivatingproteinsstructures pages 12-14, mozzarelli2024functionalandstructural pages 6-7, paul2025thec2domain pages 4-6).<br />
- Safety considerations in T cell engineering: While RASA2 loss-of-function can enhance engineered T cells, RASA2 is a tumor suppressor recurrently altered in melanoma; therefore, experts suggest pairing edits with orthogonal safeguards (e.g., TRAC knock-in to eliminate endogenous TCR) and careful preclinical evaluation (Nature 2022; 2024 CAR-T engineering reviews) (carnevale2022rasa2ablationin pages 8-9, song2024crisprcasbasedcartcells pages 7-9, lei2024leveragingcrisprgene pages 20-21).</p>
<p>Relevant statistics and recent data<br />
- Melanoma frequency/co-mutation: In the 254-patient cohort (2013‚Äì2023), RASA2 alterations were present in 22 cases (8.7%). NF1 significantly co-occurred with RASA2 loss (Pearson r=0.37, adjusted p&lt;0.001), and triple-wild-type tumors sometimes harbored RASA2 as part of MAPK-pathway alterations, consistent with pathway dysregulation in melanoma (https://doi.org/10.3390/cancers16071347; Jan 2024) (haugh2024targeteddnasequencing pages 7-9).<br />
- Engineered T cells (functional outcomes): RASA2 knockout T cells showed increased MAPK signalling, cytokine production, antigen-dim target killing, metabolic fitness, and in vivo competitive advantage with prolonged animal survival across models (Nature 2022), consolidated in 2024 reviews (carnevale2022rasa2ablationin pages 8-9, song2024crisprcasbasedcartcells pages 7-9, lei2024leveragingcrisprgene pages 20-21).<br />
- NSCLC radioresistance association: In patient tumor analyses and orthotopic mouse models, higher RASA2 associated with lower ORR after radiotherapy and reduced apoptosis via p53 modulation (https://doi.org/10.21037/tlcr-24-160; Mar 2024) (li2024theroleof pages 1-3).</p>
<p>Pathway placement and cellular role<br />
- Primary pathway: RASA2 negatively regulates the RAS‚ÄìRAF‚ÄìMEK‚ÄìERK cascade by accelerating Ras GTP hydrolysis; its lipid-binding domains coordinate membrane recruitment, ensuring spatial coupling of Ras inactivation with effector engagement. Loss or reduction of RASA2 increases RAS-GTP and downstream MAPK signalling, with context-specific effects on PI3K/other effectors depending on cellular localization and effector competition (Molecular Cell 2024; Kinases &amp; Phosphatases 2023) (mozzarelli2024functionalandstructural pages 6-7, nair2023regulationofrasgtpase pages 10-12).</p>
<p>Study summary table (2023‚Äì2024 highlights)<br />
| Year | Study / Type | Main finding about RASA2 | Disease / Context | URL | Publication date (month/year) |<br />
|------|--------------|--------------------------|-------------------|-----|----------------------------|<br />
| 2024 | Haugh et al. ‚Äî Targeted DNA sequencing (Cancers) | RASA2 recurrently altered in cutaneous melanoma (n=22 in cohort); frequently co-mutated with NF1 and implicated in MAPK-pathway dysregulation (haugh2024targeteddnasequencing pages 7-9) | Cutaneous melanoma genomics | https://doi.org/10.3390/cancers16071347 | Jan 2024 |<br />
| 2024 | Li et al. ‚Äî Translational Lung Cancer Research | Elevated RASA2 linked to radioresistance via promotion of p53 phosphorylation/degradation and reduced apoptosis; high RASA2 associated with poorer radiotherapy response (li2024theroleof pages 1-3) | Non-small cell lung cancer (radioresistance) | https://doi.org/10.21037/tlcr-24-160 | Mar 2024 |<br />
| 2024 | Song et al. ‚Äî Review (Biomarker Research) | Summarizes CRISPR/Cas CAR-T engineering literature and notes RASA2 identified by CRISPR screens as an intracellular checkpoint whose KO enhances T cell MAPK signalling and cytotoxicity (song2024crisprcasbasedcartcells pages 7-9) | CAR-T engineering / immunotherapy | https://doi.org/10.1186/s40364-024-00602-z | May 2024 |<br />
| 2024 | Lei et al. ‚Äî Review (Leukemia) | Reviews CRISPR strategies to optimize CAR-T cells and highlights RASA2 as a screen-derived checkpoint target for improving engineered T cell function (lei2024leveragingcrisprgene pages 20-21) | CAR-T and leukemia applications | https://doi.org/10.1038/s41375-024-02444-y | Oct 2024 |<br />
| 2024 | Mozzarelli et al. ‚Äî Review (Molecular Cell) | Contextualizes Ras effector regulation and RasGAP function, supporting RASA2's role as a RasGAP that modulates RAS-MAPK signalling and localization (mozzarelli2024functionalandstructural pages 6-7) | RAS signalling biology / mechanism | https://doi.org/10.1016/j.molcel.2024.06.027 | Aug 2024 |</p>
<p><em>Table: Concise table summarizing major 2023‚Äì2024 publications on human RASA2 covering melanoma genomics, radioresistance, RAS signalling context, and CRISPR/CAR‚ÄëT engineering; each main finding includes a context citation for traceability.</em></p>
<p>Conclusion<br />
Human RASA2 (Q15283) encodes a RasGAP with C2 and PH domains that localize/regulate its catalytic activity toward Ras, acting as a negative regulator of RAS‚ÄìMAPK signalling at membranes. Recent genomics shows recurrent RASA2 alteration in melanoma with significant co-occurrence with NF1 loss, consistent with tumor-suppressor function. Emerging translational data link high RASA2 to radioresistance in NSCLC via p53 modulation. In cell therapy engineering, RASA2 knockout enhances CAR/TCR T cell antigen sensitivity, function, and persistence in preclinical models; 2024 reviews incorporate RASA2 among prioritized intracellular checkpoints for CRISPR engineering. Together, structural, mechanistic, and translational evidence position RASA2 as a membrane-localized RasGAP whose modulation has implications across oncology and engineered immunity (scheffzek2019rasspecificgtpaseactivatingproteinsstructures pages 12-14, paul2025thec2domain pages 4-6, haugh2024targeteddnasequencing pages 7-9, li2024theroleof pages 1-3, carnevale2022rasa2ablationin pages 8-9, song2024crisprcasbasedcartcells pages 7-9, lei2024leveragingcrisprgene pages 20-21).</p>
<p>References</p>
<ol>
<li>
<p>(scheffzek2019rasspecificgtpaseactivatingproteinsstructures pages 12-14): Klaus Scheffzek and Giridhar Shivalingaiah. Ras-specific gtpase-activating proteins-structures, mechanisms, and interactions. Cold Spring Harbor perspectives in medicine, 9 3:a031500, Aug 2019. URL: https://doi.org/10.1101/cshperspect.a031500, doi:10.1101/cshperspect.a031500. This article has 104 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(paul2025thec2domain pages 4-6): Maxum E. Paul, Di Chen, Kimberly J. Vish, Nathaniel L. Lartey, Elizabeth Hughes, Zachary T. Freeman, Thomas L. Saunders, Amy L. Stiegler, Philip D. King, and Titus J. Boggon. The c2 domain augments ras gtpase-activating protein catalytic activity. Proceedings of the National Academy of Sciences of the United States of America, Feb 2025. URL: https://doi.org/10.1073/pnas.2418433122, doi:10.1073/pnas.2418433122. This article has 4 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(carnevale2022rasa2ablationin pages 1-2): Julia Carnevale, Eric Shifrut, Nupura Kale, William A. Nyberg, Franziska Blaeschke, Yan Yi Chen, Zhongmei Li, Sagar P. Bapat, Morgan E. Diolaiti, Patrick O‚ÄôLeary, Shane Vedova, Julia Belk, Bence Daniel, Theodore L. Roth, Stefanie Bachl, Alejandro Allo Anido, Brooke Prinzing, Jorge Iba√±ez-Vega, Shannon Lange, Dalia Haydar, Marie Luetke-Eversloh, Maelys Born-Bony, Bindu Hegde, Scott Kogan, Tobias Feuchtinger, Hideho Okada, Ansuman T. Satpathy, Kevin Shannon, Stephen Gottschalk, Justin Eyquem, Giedre Krenciute, Alan Ashworth, and Alexander Marson. Rasa2 ablation in t cells boosts antigen sensitivity and long-term function. Nature, 609:174-182, Aug 2022. URL: https://doi.org/10.1038/s41586-022-05126-w, doi:10.1038/s41586-022-05126-w. This article has 209 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(mozzarelli2024functionalandstructural pages 6-7): Alessandro M. Mozzarelli, Dhirendra K. Simanshu, and Pau Castel. Functional and structural insights into ras effector proteins. Molecular Cell, 84:2807-2821, Aug 2024. URL: https://doi.org/10.1016/j.molcel.2024.06.027, doi:10.1016/j.molcel.2024.06.027. This article has 20 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(nair2023regulationofrasgtpase pages 10-12): Arathi Nair and Bhaskar Saha. Regulation of ras-gtpase signaling and localization by post-translational modifications. Kinases and Phosphatases, 1:97-116, Apr 2023. URL: https://doi.org/10.3390/kinasesphosphatases1020007, doi:10.3390/kinasesphosphatases1020007. This article has 5 citations.</p>
</li>
<li>
<p>(haugh2024targeteddnasequencing pages 7-9): Alexandra M. Haugh, Robert C. Osorio, Rony A. Francois, Michael E. Tawil, Katy K. Tsai, Michael Tetzlaff, Adil Daud, and Harish N. Vasudevan. Targeted dna sequencing of cutaneous melanoma identifies prognostic and predictive alterations. Cancers, Jan 2024. URL: https://doi.org/10.3390/cancers16071347, doi:10.3390/cancers16071347. This article has 6 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(bellazzo2020cuttingthebrakes pages 15-17): Arianna Bellazzo and Licio Collavin. Cutting the brakes on ras‚Äîcytoplasmic gaps as targets of inactivation in cancer. Cancers, 12:3066, Oct 2020. URL: https://doi.org/10.3390/cancers12103066, doi:10.3390/cancers12103066. This article has 19 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(li2024theroleof pages 1-3): Jie Li, Yan Zong, Zhan Tuo, Junwei Liu, and Jun Liu. The role of rasa2 in predicting radioresistance in lung cancer through regulation of p53. Translational Lung Cancer Research, 13:587-602, Mar 2024. URL: https://doi.org/10.21037/tlcr-24-160, doi:10.21037/tlcr-24-160. This article has 4 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(carnevale2022rasa2ablationin pages 8-9): Julia Carnevale, Eric Shifrut, Nupura Kale, William A. Nyberg, Franziska Blaeschke, Yan Yi Chen, Zhongmei Li, Sagar P. Bapat, Morgan E. Diolaiti, Patrick O‚ÄôLeary, Shane Vedova, Julia Belk, Bence Daniel, Theodore L. Roth, Stefanie Bachl, Alejandro Allo Anido, Brooke Prinzing, Jorge Iba√±ez-Vega, Shannon Lange, Dalia Haydar, Marie Luetke-Eversloh, Maelys Born-Bony, Bindu Hegde, Scott Kogan, Tobias Feuchtinger, Hideho Okada, Ansuman T. Satpathy, Kevin Shannon, Stephen Gottschalk, Justin Eyquem, Giedre Krenciute, Alan Ashworth, and Alexander Marson. Rasa2 ablation in t cells boosts antigen sensitivity and long-term function. Nature, 609:174-182, Aug 2022. URL: https://doi.org/10.1038/s41586-022-05126-w, doi:10.1038/s41586-022-05126-w. This article has 209 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(carnevale2022rasa2ablationin pages 7-8): Julia Carnevale, Eric Shifrut, Nupura Kale, William A. Nyberg, Franziska Blaeschke, Yan Yi Chen, Zhongmei Li, Sagar P. Bapat, Morgan E. Diolaiti, Patrick O‚ÄôLeary, Shane Vedova, Julia Belk, Bence Daniel, Theodore L. Roth, Stefanie Bachl, Alejandro Allo Anido, Brooke Prinzing, Jorge Iba√±ez-Vega, Shannon Lange, Dalia Haydar, Marie Luetke-Eversloh, Maelys Born-Bony, Bindu Hegde, Scott Kogan, Tobias Feuchtinger, Hideho Okada, Ansuman T. Satpathy, Kevin Shannon, Stephen Gottschalk, Justin Eyquem, Giedre Krenciute, Alan Ashworth, and Alexander Marson. Rasa2 ablation in t cells boosts antigen sensitivity and long-term function. Nature, 609:174-182, Aug 2022. URL: https://doi.org/10.1038/s41586-022-05126-w, doi:10.1038/s41586-022-05126-w. This article has 209 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(song2024crisprcasbasedcartcells pages 7-9): Ping Song, Qiqi Zhang, Zhiyong Xu, Yuelin Shi, Ruirui Jing, and Dingcun Luo. Crispr/cas-based car-t cells: production and application. Biomarker Research, May 2024. URL: https://doi.org/10.1186/s40364-024-00602-z, doi:10.1186/s40364-024-00602-z. This article has 34 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(lei2024leveragingcrisprgene pages 20-21): Tao Lei, Yazhuo Wang, Yuchen Zhang, Yufei Yang, Jiaying Cao, Jiansong Huang, Jiali Chen, Huajing Chen, Jiayi Zhang, Luzheng Wang, Xinjie Xu, Robert Peter Gale, and Liang Wang. Leveraging crispr gene editing technology to optimize the efficacy, safety and accessibility of car t-cell therapy. Leukemia, 38:2517-2543, Oct 2024. URL: https://doi.org/10.1038/s41375-024-02444-y, doi:10.1038/s41375-024-02444-y. This article has 69 citations and is from a highest quality peer-reviewed journal.</p>
</li>
</ol>
<h2 id="citations">Citations</h2>
<ol>
<li>haugh2024targeteddnasequencing pages 7-9</li>
<li>li2024theroleof pages 1-3</li>
<li>song2024crisprcasbasedcartcells pages 7-9</li>
<li>lei2024leveragingcrisprgene pages 20-21</li>
<li>mozzarelli2024functionalandstructural pages 6-7</li>
<li>scheffzek2019rasspecificgtpaseactivatingproteinsstructures pages 12-14</li>
<li>nair2023regulationofrasgtpase pages 10-12</li>
<li>bellazzo2020cuttingthebrakes pages 15-17</li>
<li>https://doi.org/10.1038/s41586-022-05126-w;</li>
<li>https://doi.org/10.1073/pnas.2418433122;</li>
<li>https://doi.org/10.1101/cshperspect.a031500;</li>
<li>https://doi.org/10.1016/j.molcel.2024.06.027;</li>
<li>https://doi.org/10.3390/kinasesphosphatases1020007;</li>
<li>https://doi.org/10.3390/cancers16071347;</li>
<li>https://doi.org/10.3390/cancers12103066;</li>
<li>https://doi.org/10.1172/jci177270;</li>
<li>https://doi.org/10.21037/tlcr-24-160;</li>
<li>https://doi.org/10.1186/s40364-024-00602-z;</li>
<li>https://doi.org/10.1038/s41375-024-02444-y</li>
<li>https://doi.org/10.1073/pnas.2418433122</li>
<li>https://doi.org/10.3390/cancers16071347</li>
<li>https://doi.org/10.21037/tlcr-24-160</li>
<li>https://doi.org/10.1186/s40364-024-00602-z</li>
<li>https://doi.org/10.1016/j.molcel.2024.06.027</li>
<li>https://doi.org/10.1101/cshperspect.a031500,</li>
<li>https://doi.org/10.1073/pnas.2418433122,</li>
<li>https://doi.org/10.1038/s41586-022-05126-w,</li>
<li>https://doi.org/10.1016/j.molcel.2024.06.027,</li>
<li>https://doi.org/10.3390/kinasesphosphatases1020007,</li>
<li>https://doi.org/10.3390/cancers16071347,</li>
<li>https://doi.org/10.3390/cancers12103066,</li>
<li>https://doi.org/10.21037/tlcr-24-160,</li>
<li>https://doi.org/10.1186/s40364-024-00602-z,</li>
<li>https://doi.org/10.1038/s41375-024-02444-y,</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Openai</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(RASA2-deep-research-openai.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q15283" data-a="DOC: Deep Research Openai" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: openai<br />
model: o3-deep-research-2025-06-26<br />
cached: true<br />
start_time: '2025-11-04T00:10:36.599422'<br />
end_time: '2025-11-04T00:10:36.611892'<br />
duration_seconds: 0.01<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: Q15283<br />
  gene_symbol: RASA2<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    temperature: 0.1<br />
    top_p: 1.0<br />
citation_count: 68</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<p>Please provide a comprehensive research report on the gene RASA2 (Q15283) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function. </p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<h1 id="functional-annotation-of-human-rasa2-q15283">Functional Annotation of Human RASA2 (Q15283)</h1>
<h2 id="gene-and-protein-overview">Gene and Protein Overview</h2>
<p><strong>RASA2</strong> (RAS p21 protein activator 2, UniProt Q15283) is a human gene encoding a Ras GTPase-activating protein (Ras GAP) that <strong>turns off Ras signaling</strong> by accelerating the hydrolysis of Ras-bound GTP (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=RASA2%20and%20RASA3%2C%20which%20are,T%20cell%20activation%20and%20migration">pmc.ncbi.nlm.nih.gov</a>). The RASA2 protein belongs to the GAP1 family of Ras GAPs and is sometimes referred to by the alias <strong>GAP1(m)</strong> (<a href="https://www.ncbi.nlm.nih.gov/gene/5922#:~:text=Also%20known%20as%20GAP1M%20Summary,form%20of%20RAS%2C%20thereby%20allowing">www.ncbi.nlm.nih.gov</a>). By enhancing Ras‚Äôs weak intrinsic GTPase activity, RASA2 promotes conversion of active <strong>Ras‚ÄìGTP to inactive Ras‚ÄìGDP</strong>, thereby suppressing Ras function (<a href="https://www.ncbi.nlm.nih.gov/gene/5922#:~:text=Summary%20The%20protein%20encoded%20by,provided%20by%20RefSeq%2C%20Dec%202014">www.ncbi.nlm.nih.gov</a>). This ‚Äúoff-switch‚Äù role allows RASA2 to control downstream signaling pathways that drive cell proliferation and differentiation (<a href="https://www.ncbi.nlm.nih.gov/gene/5922#:~:text=Summary%20The%20protein%20encoded%20by,provided%20by%20RefSeq%2C%20Dec%202014">www.ncbi.nlm.nih.gov</a>). Importantly, RASA2 stimulates GTP hydrolysis on <strong>normal Ras (p21)</strong> but is ineffective on certain oncogenic Ras mutants (e.g. Ras^G12V), which are resistant to GAPs (<a href="https://www.ncbi.nlm.nih.gov/gene/5922#:~:text=Summary%20The%20protein%20encoded%20by,provided%20by%20RefSeq%2C%20Dec%202014">www.ncbi.nlm.nih.gov</a>). In essence, RASA2 is a negative regulator of Ras, helping maintain appropriate Ras activity levels in cells.</p>
<h2 id="protein-structure-and-localization">Protein Structure and Localization</h2>
<p>The RASA2 protein is a multi-domain cytosolic protein that can <strong>associate with the inner surface of the plasma membrane</strong> in response to signaling cues. It has a conserved C-terminal <strong>RasGAP domain</strong> responsible for its catalytic activity, and N-terminal regulatory domains typical of the GAP1 family (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=domain%20structures%2C%20including%20GAP%20domains,The%20RASA3%20PH%20domain">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=A,through%20a%20distinct">pmc.ncbi.nlm.nih.gov</a>). Notably, RASA2 contains <strong>two tandem C2 domains</strong> (calcium-dependent phospholipid-binding domains) and a <strong>pleckstrin homology (PH) domain</strong>, also known as a BTK-type PH domain (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=domain%20structures%2C%20including%20GAP%20domains,The%20RASA3%20PH%20domain">pmc.ncbi.nlm.nih.gov</a>). These domains mediate lipid binding and subcellular targeting: for example, the PH domains of RASA2 and its close relative RASA3 bind strongly to the membrane lipid <strong>phosphatidylinositol (3,4,5)-trisphosphate (PIP‚ÇÉ)</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=which%20includes%20RASAL1%20,4%7D%29%20and">pmc.ncbi.nlm.nih.gov</a>). In fact, high-resolution pull-down experiments identified RASA2 as a PIP‚ÇÉ-binding protein, indicating that RASA2 is recruited to PIP‚ÇÉ-enriched membranes (such as activated receptor signaling sites) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=domain%20structures%2C%20including%20GAP%20domains,The%20RASA3%20PH%20domain">pmc.ncbi.nlm.nih.gov</a>). The C2 domains can bind membranes in a Ca¬≤‚Å∫-dependent manner, suggesting that calcium signals may also promote RASA2 membrane localization (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=domain%20structures%2C%20including%20GAP%20domains,The%20RASA3%20PH%20domain">pmc.ncbi.nlm.nih.gov</a>). Together, these domains allow RASA2 to shuttle from the cytosol to the plasma membrane where its substrate Ras resides. RASA2 <strong>lacks transmembrane regions</strong> and is not secreted; it functions inside the cell, with its activity occurring at the cytosol‚Äìinner membrane interface. Consistent with a general signaling role, RASA2 is <strong>broadly expressed across tissues</strong>, with particularly notable expression in immune and lymphoid organs (<a href="https://www.ncbi.nlm.nih.gov/gene/5922#:~:text=The%20protein%20encoded%20by%20this,9%29%20and%2024">www.ncbi.nlm.nih.gov</a>). This widespread distribution reflects its fundamental role in regulating Ras signals in many cell types.</p>
<h2 id="biochemical-function-and-mechanism">Biochemical Function and Mechanism</h2>
<p>As a Ras GTPase-activating protein, RASA2‚Äôs <strong>primary biochemical function</strong> is to catalyze the inactivation of Ras by accelerating Ras‚Äôs GTPase activity. Ras proteins are molecular switches that toggle between an active GTP-bound state and an inactive GDP-bound state. RASA2 <strong>binds to active Ras‚ÄìGTP and inserts a ‚Äúcatalytic arginine finger‚Äù into Ras‚Äôs active site</strong>, greatly accelerating GTP hydrolysis (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=B%29%20RAS,through%20a%20distinct">pmc.ncbi.nlm.nih.gov</a>). In the human RASA2 protein, the critical arginine residue is <strong>Arg-511</strong>, which is contributed into the Ras catalytic site to stimulate GTP cleavage to GDP (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=A,through%20a%20distinct">pmc.ncbi.nlm.nih.gov</a>). This mechanism is analogous to other Ras GAPs (such as p120^RasGAP/RASA1 and neurofibromin), whereby the GAP protein provides an arginine residue that complements Ras‚Äôs active-site chemistry and induces GTP breakdown (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=A,through%20a%20distinct">pmc.ncbi.nlm.nih.gov</a>). Through this enzymatic action, RASA2 <strong>converts Ras-GTP (active) to Ras-GDP (inactive)</strong>, effectively terminating the Ras signal. The ‚Äúsubstrate‚Äù of RASA2 is Ras (primarily H-Ras, N-Ras, K-Ras and related small GTPases in the Ras subfamily) in its GTP-bound form. RASA2 shows specificity for normal (wild-type) Ras and does not effectively stimulate hydrolysis on mutant Ras proteins that carry activating oncogenic mutations (<a href="https://www.ncbi.nlm.nih.gov/gene/5922#:~:text=Summary%20The%20protein%20encoded%20by,provided%20by%20RefSeq%2C%20Dec%202014">www.ncbi.nlm.nih.gov</a>). Some GAP1 family members are known to act on the Ras-related GTPase Rap1 as well as Ras (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=Several%20RAS,specific%20GAPs%20%5B%2041%2C54">pmc.ncbi.nlm.nih.gov</a>); however, <strong>RASA2 is chiefly a Ras-specific GAP</strong> in physiological contexts, whereas the related RASA3 (GAP1^IP4BP) predominantly inactivates Rap1 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=RASA2%20and%20RASA3%2C%20which%20are,T%20cell%20activation%20and%20migration">pmc.ncbi.nlm.nih.gov</a>). By turning off Ras, RASA2 <strong>attenuates downstream signaling cascades</strong> initiated by Ras, most prominently the <strong>RAF‚ÄìMEK‚ÄìERK (MAP kinase) pathway</strong> which controls cell growth and differentiation. In this way, RASA2 acts as a molecular brake in signaling pathways that require timely shutdown of Ras activity.</p>
<h2 id="biological-role-in-signaling-pathways">Biological Role in Signaling Pathways</h2>
<p><strong>RASA2 plays a critical role in regulating Ras-dependent signaling pathways</strong>, thereby influencing various cellular processes. Ras activation is a key step in pathways downstream of many receptors (e.g. growth factor receptors, cytokine receptors, antigen receptors), leading to outcomes such as proliferation, differentiation, and survival. RASA2 provides negative feedback in these pathways by ensuring that Ras activation is transient and appropriately scaled. For example, in growth factor signaling, receptor tyrosine kinases activate Ras (via Ras GEFs like SOS or RasGRP), and RASA2 can bind to the membrane (through its PH domain binding PIP‚ÇÉ generated by receptor-activated PI3K) to inactivate Ras and terminate the signal (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=which%20includes%20RASAL1%20,4%7D%29%20and">pmc.ncbi.nlm.nih.gov</a>). This feedback loop prevents over-activation of the Ras‚ÄìMAPK cascade, thereby maintaining normal control of cell proliferation. Consistently, loss of RASA2 leads to <strong>prolonged or enhanced Ras signaling</strong>, which can drive excessive cell growth and other aberrant behaviors (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12071082/#:~:text=%5B104%5D.%20Furthermore%2C%20loss,the%20Ras%20signaling%20pathway%2C%20potentially">pmc.ncbi.nlm.nih.gov</a>). </p>
<p>One well-studied context for RASA2 function is in <strong>T lymphocyte signaling</strong>. Ras activation is essential for T-cell receptor (TCR) signaling, leading to downstream ERK/MAPK activation important for T cell proliferation and activation. Recent genetic screens in primary human T cells identified RASA2 as a crucial ‚Äúbrake‚Äù on TCR signaling (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=Repeats,these%20GAPs%2C%20how%20they%20are">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=,Figure%201">pmc.ncbi.nlm.nih.gov</a>). <strong>RASA2 is expressed in both CD4‚Å∫ and CD8‚Å∫ T cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L349%20,in%20T%20cells%20remained%20unexplored">pmc.ncbi.nlm.nih.gov</a>)</strong>, and when T cells are stimulated via the TCR, RASA2 normally acts to limit Ras activity and downstream activation. In experiments using CRISPR/Cas9 knockout, <strong>loss of RASA2 resulted in a roughly 2-fold increase in T cell proliferation upon stimulation</strong>, along with upregulation of activation markers (such as CD69 and CD154) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L356%20Figure%202A,TCR">pmc.ncbi.nlm.nih.gov</a>). RASA2-deficient T cells also showed enhanced functional outcomes ‚Äì for instance, T cells lacking RASA2 had <strong>heightened sensitivity to antigen and killed target cancer cells more efficiently in co-culture assays</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L360%20antibodies%20in,2%2C3">pmc.ncbi.nlm.nih.gov</a>). Notably, RASA2 knockout T cells proliferated more robustly even under typically suppressive conditions (presence of immunosuppressive factors like adenosine, TGF-Œ≤, or regulatory T cells) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L373%20succinimidyl%20ester,reg%7D%20cells%20%5B2%2C3%5D.%20Cells%20were">pmc.ncbi.nlm.nih.gov</a>). These findings demonstrate that <strong>RASA2 serves as a gatekeeper in the TCR signaling pathway</strong>, restraining Ras/MAPK pathway activation to keep T cell responses in check (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=Repeats,these%20GAPs%2C%20how%20they%20are">pmc.ncbi.nlm.nih.gov</a>). When RASA2 is removed, Ras signaling goes unchecked, resulting in hyperactive T cell responses. This precise role in T cells exemplifies how RASA2 functions in signaling pathways: by dampening Ras activity, it modulates the magnitude of downstream biological responses (in this case, cell proliferation and effector function). Such negative regulation is crucial for maintaining immune homeostasis and preventing over-activation.</p>
<p>Beyond T cells, RASA2 is thought to perform a similar <strong>homeostatic role in other cell types</strong>. It contributes to controlling Ras-dependent pathways in development and differentiation. Indeed, <strong>germline mutations in RASA2 have been identified in Noonan syndrome</strong>, a developmental disorder (Rasopathy) caused by hyperactive Ras/MAPK signaling (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=RASA2%20was%20identified%20as%20an,defects%20and%20elevated%20RAS%20activity">pmc.ncbi.nlm.nih.gov</a>). Although RASA2 mutations appear to be a rare cause of Noonan syndrome, their occurrence underscores that RASA2‚Äôs regulatory function is important in normal human development ‚Äì loss of RASA2 can elevate Ras signaling enough to produce developmental abnormalities (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=RASA2%20was%20identified%20as%20an,defects%20and%20elevated%20RAS%20activity">pmc.ncbi.nlm.nih.gov</a>). In summary, RASA2 operates in multiple signaling contexts as a negative regulator: it ensures that Ras-driven pathways (like the MAPK cascade) are properly shut off, thereby influencing cell proliferation, differentiation, and activation in a tightly controlled manner.</p>
<h2 id="structural-features-and-regulatory-interactions">Structural Features and Regulatory Interactions</h2>
<p>The multi-domain structure of RASA2 hints at mechanisms by which its activity is regulated within the cell. The <strong>pleckstrin homology (PH) domain</strong> of RASA2 binds membrane phosphoinositides, especially PIP‚ÇÉ, with high affinity (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=which%20includes%20RASAL1%20,4%7D%29%20and">pmc.ncbi.nlm.nih.gov</a>). This means that when PI3K enzymes produce PIP‚ÇÉ (for instance, during receptor signaling), RASA2 can be <strong>recruited to the plasma membrane</strong> via its PH domain. Co-localization at the membrane brings RASA2 into proximity with active Ras, enabling it to inactivate Ras at the site of signal transduction. Thus, <strong>PIP‚ÇÉ acts as a docking signal for RASA2</strong>, coupling PI3K activation to Ras signal termination. This is a form of crosstalk between the PI3K pathway and Ras pathway: the generation of PIP‚ÇÉ not only triggers AKT signaling but also helps initiate negative feedback on Ras through RASA2‚Äôs recruitment (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=which%20includes%20RASAL1%20,4%7D%29%20and">pmc.ncbi.nlm.nih.gov</a>). </p>
<p>The <strong>tandem C2 domains</strong> in RASA2 likely mediate additional regulatory interactions. C2 domains typically bind acidic phospholipids in a calcium-dependent manner. While RASA2‚Äôs C2 domains have not been studied as extensively as those of RASA4/CAPRI (a calcium-promoted Ras GAP), their presence suggests that <strong>calcium fluxes might enhance RASA2‚Äôs membrane association or activity</strong>. For example, analogies to RASA4 (which translocates to the membrane upon Ca¬≤‚Å∫ signals) raise the possibility that RASA2 could respond to Ca¬≤‚Å∫ increases by a similar mechanism (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=domain%20structures%2C%20including%20GAP%20domains,The%20RASA3%20PH%20domain">pmc.ncbi.nlm.nih.gov</a>). In combination, the PH and C2 domains position RASA2 as a <strong>signal-responsive inhibitor</strong>: it integrates second messengers (like lipid products and Ca¬≤‚Å∫) to modulate when and where it turns off Ras. Structurally, RASA2 does not contain SH2 or SH3 domains (domains found in some other Ras regulators like RASA1/p120^RasGAP), so it may not directly bind phosphotyrosine sites on receptors. Instead, RASA2 relies on lipid-binding for localization, and potentially partners with other proteins via its PH/C2 regions or other motifs. There is evidence that <strong>RASA2 can form signaling complexes</strong> at the membrane; for instance, earlier studies showed that the closely related GAP1 family member (RASA3) binds inositol 1,3,4,5-tetrakisphosphate (IP‚ÇÑ) and PIP‚ÇÇ, suggesting complex regulatory ligand interactions (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=affinity%20for%20PI%283%2C4%2C5%29P_,2%7D%20%5B%2050%2C32">pmc.ncbi.nlm.nih.gov</a>). RASA2‚Äôs PH domain, in particular, shows specificity for PIP‚ÇÉ, which may distinguish its recruitment profile from RASA3 or RASAL1 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=which%20includes%20RASAL1%20,2%7D%20%5B%2050%2C32">pmc.ncbi.nlm.nih.gov</a>). </p>
<p>On the enzymatic side, RASA2‚Äôs activity can be inferred to be subject to <strong>feedback regulation</strong>. When Ras is active, one of its downstream effects is to activate PI3K, raising PIP‚ÇÉ levels; this in turn recruits RASA2 to dampen Ras ‚Äì a negative feedback loop. Conversely, if Ras signaling is minimal, RASA2 may remain diffuse in the cytosol (less membrane-bound). This dynamic localization has been observed for similar GAP1 family proteins. In addition, <strong>post-translational modifications</strong> could regulate RASA2 (though specific modifications are not well characterized in literature as of current knowledge). By analogy, other Ras GAPs are known to be phosphorylated or cleaved in certain conditions (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12071082/#:~:text=Mutations%20in%20RASGAPs%20also%20play,of%20RASGAPs%20promote%20tumorigenesis%20by">pmc.ncbi.nlm.nih.gov</a>). One example in the broader GAP family: caspase-3 can cleave p120^RasGAP (RASA1) during apoptosis, enhancing Ras signaling in dying cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12071082/#:~:text=Mutations%20in%20RASGAPs%20also%20play,of%20RASGAPs%20promote%20tumorigenesis%20by">pmc.ncbi.nlm.nih.gov</a>). It‚Äôs reported that a point mutation preventing a RasGAP‚Äôs cleavage led to prolonged Ras activity (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12071082/#:~:text=Mutations%20in%20RASGAPs%20also%20play,of%20RASGAPs%20promote%20tumorigenesis%20by">pmc.ncbi.nlm.nih.gov</a>). Whether RASA2 undergoes similar regulatory phosphorylation or proteolysis remains to be fully explored, but these are potential layers of control. In summary, <strong>RASA2‚Äôs function is tightly linked to its structural domains</strong>: the PH and C2 domains target it to the membrane in response to lipid/Ca¬≤‚Å∫ signals, and the GAP domain then executes Ras inactivation. This design ensures RASA2 is activated at the right place and time to modulate Ras signaling. </p>
<h2 id="physiological-and-clinical-significance">Physiological and Clinical Significance</h2>
<p><strong>RASA2 is vital for normal cellular homeostasis</strong>, and its dysfunction has been implicated in human diseases that center on aberrant Ras signaling. Here are key contexts in which RASA2‚Äôs role has been highlighted:</p>
<ul>
<li>
<p><strong>Tumor Suppressor in Cancer:</strong> RASA2 has emerged as a <strong>tumor suppressor gene</strong>, particularly in melanoma. A large-scale sequencing of 501 melanomas identified recurrent inactivating mutations in <em>RASA2</em> in about <strong>5% of melanoma tumors</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4954601/#:~:text=Analysis%20of%20501%20melanoma%20exomes,of%20Ras%20GAPs%20in%20cancer">pmc.ncbi.nlm.nih.gov</a>). Many of these mutations are nonsense or frameshift changes predicted to eliminate RASA2 function (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4954601/#:~:text=mutations%20encompass%20at%20least%2020,the%20CytoScan%20High%20Definition%20array">pmc.ncbi.nlm.nih.gov</a>). Functional studies showed that loss of RASA2 leads to enhanced Ras‚ÄìERK signaling in melanoma cells, driving increased cell proliferation, survival, and <strong>cell migration</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4954601/#:~:text=Analysis%20of%20501%20melanoma%20exomes,of%20Ras%20GAPs%20in%20cancer">pmc.ncbi.nlm.nih.gov</a>). In cell-based assays, reintroducing RASA2 or restoring its function curbed melanoma cell growth and motility, consistent with Ras pathway suppression (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4954601/#:~:text=Analysis%20of%20501%20melanoma%20exomes,of%20Ras%20GAPs%20in%20cancer">pmc.ncbi.nlm.nih.gov</a>). Clinically, RASA2 protein expression is absent or greatly reduced in a significant fraction of melanomas ‚Äì <strong>at least 30% of cases show loss of RASA2 expression</strong>, often due to gene deletion or epigenetic silencing (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4954601/#:~:text=Analysis%20of%20501%20melanoma%20exomes,of%20Ras%20GAPs%20in%20cancer">pmc.ncbi.nlm.nih.gov</a>). Importantly, melanoma patients whose tumors lack RASA2 tend to have <strong>worse outcomes</strong>, suggesting that RASA2 loss confers a more aggressive, Ras-driven disease course (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4954601/#:~:text=Analysis%20of%20501%20melanoma%20exomes,importance%20of%20Ras%20GAPs%20in">pmc.ncbi.nlm.nih.gov</a>). These findings (Arafeh <em>et al.</em>, <em>Nat. Genet.</em>, 2015) establish that disabling RASA2 is one way tumors achieve unchecked Ras activity. In other cancers, RASA2 mutations are less frequent but have been observed. For instance, loss-of-function RASA2 variants have been noted in some <strong>lung cancers and colon cancers</strong> (often alongside other Ras pathway alterations), although detailed frequencies are still being investigated (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12071082/#:~:text=Mutations%20in%20RASGAPs%20also%20play,of%20RASGAPs%20promote%20tumorigenesis%20by">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12071082/#:~:text=cell%20lung%20cancer%20,pathological%20implications%20in%20urological%20malignancies">pmc.ncbi.nlm.nih.gov</a>). The unifying theme is that <strong>cancer cells can inactivate RASA2 to escape its restraining effect on Ras</strong>, thereby gaining a growth advantage. RASA2‚Äôs status as a tumor suppressor places it among several Ras pathway negative regulators (like NF1, RASA1, and SPRED1) that are mutated in cancers to enable hyperactive Ras signaling.</p>
</li>
<li>
<p><strong>Rasopathies and Developmental Disorders:</strong> Germline mutations in the Ras/MAPK pathway cause a group of developmental syndromes known as <strong>Rasopathies</strong>. Noonan syndrome is one such condition, typically arising from mutations in genes like <em>PTPN11</em> (SHP2), <em>SOS1</em>, <em>KRAS/NRAS</em>, or <em>RAF1</em>. Notably, <strong>rare mutations in <em>RASA2</em></strong> have also been found in Noonan syndrome patients (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=RASA2%20was%20identified%20as%20an,defects%20and%20elevated%20RAS%20activity">pmc.ncbi.nlm.nih.gov</a>). A 2014 genomic study identified <em>RASA2</em> variants in individuals with Noonan syndrome who did not have the more common mutations (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=%2A%2039.Chen%20P,PMC%20free%20article">pmc.ncbi.nlm.nih.gov</a>). These <em>RASA2</em> mutations likely reduce RASA2 function, leading to elevated Ras activity during development ‚Äì consistent with the Noonan phenotype of cardiac, facial, and growth abnormalities caused by Ras/MAPK overactivation. While <em>RASA2</em> mutations account for only a small subset of Rasopathy cases, their identification underscores the gene‚Äôs importance: even partial loss of RASA2‚Äôs Ras-GAP activity in germline can disturb developmental signaling balance. It also expands the spectrum of Ras regulators whose integrity is required for normal human development. Researchers continue to study such <em>RASA2</em> variants to understand tissue-specific effects (for example, why certain developmental pathways are sensitive to Ras hyperactivity when RASA2 is deficient).</p>
</li>
<li>
<p><strong>Immune Regulation and Immunotherapy:</strong> The discovery of RASA2‚Äôs role in T cells has implications for immunology and cancer immunotherapy. As discussed, RASA2 keeps T cell activation in check by dampening Ras signals. In conditions like chronic infections or cancer, T cells often become ‚Äúexhausted‚Äù or less responsive, partly due to inhibitory pathways. There is emerging interest in <strong>targeting RASA2 to boost T cell responses</strong> in therapies. A 2022 study demonstrated that knocking out <em>RASA2</em> in human T cells can <strong>enhance their proliferation and function over the long term</strong>, improving the cells‚Äô ability to attack cancer cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L356%20Figure%202A,TCR">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L360%20antibodies%20in,2%2C3">pmc.ncbi.nlm.nih.gov</a>). These RASA2-deficient T cells showed <strong>greater sensitivity to low levels of antigen</strong>, meaning they could respond to tumor cells that express low amounts of target, an important feature for solid tumor immunotherapy (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=,cells%20during%20exhaustion%20and%20in">pmc.ncbi.nlm.nih.gov</a>). In a preclinical model, adoptive transfer of RASA2-knockout T cells led to improved tumor control in mice, indicating that <strong>inhibiting RASA2 can strengthen anti-tumor immunity</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=,cells%20during%20exhaustion%20and%20in">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L215%20adoptive%20cell,T%20cell%20responses%20in%20mouse">pmc.ncbi.nlm.nih.gov</a>). Based on expert analysis, <strong>RASA2 is considered a promising target to modulate T cell activity</strong>: by pharmacologically inhibiting RASA2 or using gene-editing to disable it, one might reinvigorate T cells to better fight cancers (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L211%20,cells%20during%20exhaustion%20and%20in">pmc.ncbi.nlm.nih.gov</a>). Indeed, researchers have suggested that transient RASA2 inhibition could enhance T cell-based therapies (such as CAR-T cells or TCR-transduced T cells) especially against solid tumors where T cell responses are often suboptimal (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L211%20,cells%20during%20exhaustion%20and%20in">pmc.ncbi.nlm.nih.gov</a>). It should be noted, however, that any approach to inhibit RASA2 systemically must be cautious ‚Äì since RASA2 is a tumor suppressor in some contexts, completely blocking it in patients could carry a risk of unintended Ras overactivation in healthy cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L215%20adoptive%20cell,T%20cell%20responses%20in%20mouse">pmc.ncbi.nlm.nih.gov</a>). To circumvent this, strategies might focus on <strong>ex vivo RASA2 knock-out in T cells</strong> (engineering patient T cells to remove RASA2 before infusing them back, so the effect is restricted to the therapeutic cells) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=,cells%20during%20exhaustion%20and%20in">pmc.ncbi.nlm.nih.gov</a>). This area is an active topic of research and represents a real-world implementation of RASA2 functional insights: the gene, once identified as a brake on immune cells, is now a candidate handle for boosting immunotherapy.</p>
</li>
<li>
<p><strong>Drug Resistance Mechanisms:</strong> In cancer therapy, tumors often develop resistance to targeted drugs. Interestingly, loss of negative regulators like RASA2 can be a mechanism of resistance to inhibitors that act upstream of Ras. For example, <strong>SHP2 inhibitors</strong> are drugs that block an upstream activator of Ras (SHP2 is needed for efficient Ras‚ÄìGEF function). Recent CRISPR screens in cancer cell lines found that knocking out <em>RASA2</em> confers resistance to SHP2 inhibition ‚Äì without RASA2, Ras remains more active even when SHP2 is blocked (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9998968/#:~:text=To%20identify%20SHP2i%20resistance%20mechanisms%2C,sensitization%20to%20SHP2i%20required%20its">pmc.ncbi.nlm.nih.gov</a>). In these screens, <em>RASA2</em> was among the top ‚Äúhits‚Äù whose deletion led to sustained ERK pathway activation despite the presence of SHP2 inhibitor (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9998968/#:~:text=To%20identify%20SHP2i%20resistance%20mechanisms%2C,sensitization%20to%20SHP2i%20required%20its">pmc.ncbi.nlm.nih.gov</a>). This result aligns with the idea that if a tumor loses RASA2, it becomes less dependent on SHP2 or other upstream signals to keep Ras active (since Ras is intrinsically more active due to lack of GAP activity). Thus, <strong>RASA2 status could influence how tumors respond to certain therapies</strong>. Tumors with RASA2 loss-of-function might be intrinsically resistant to drugs that rely on normal Ras regulation. These insights are guiding precision medicine approaches ‚Äì for instance, screening melanomas or other cancers for <em>RASA2</em> mutations might help predict responsiveness to MAPK pathway inhibitors or combination therapies. More broadly, it highlights RASA2 as a node in the Ras network that, when removed, alters signaling fidelity and drug sensitivity.</p>
</li>
</ul>
<h2 id="expert-commentary-and-current-research-directions">Expert Commentary and Current Research Directions</h2>
<p>Experts regard RASA2 as an important <strong>regulatory hub in Ras signaling</strong>, with roles that bridge fundamental biochemistry and clinical relevance. A 2023 review in <em>Trends in Immunology</em> dubbed RASA2 (and its Rap-GAP counterpart RASA3) <strong>‚Äúgatekeepers‚Äù of T cell activation and adhesion</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=RASA2%20and%20RASA3%2C%20which%20are,T%20cell%20activation%20and%20migration">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=Repeats,these%20GAPs%2C%20how%20they%20are">pmc.ncbi.nlm.nih.gov</a>), emphasizing that these GAPs maintain immune cells in a quiescent state until appropriate activation is needed. The authors note that genetic screens have firmly placed RASA2 as a key limiting factor in T cell responses (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=Repeats,these%20GAPs%2C%20how%20they%20are">pmc.ncbi.nlm.nih.gov</a>). They discuss the exciting possibility of manipulating RASA2 for therapy ‚Äì for example, <strong>inhibiting RASA2 to enhance T cell attack on cancers</strong>, or conversely activating/augmenting RASA2 to tone down immune activation in autoimmunity (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=,T%20cell%20dysfunction%20in%20disease">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L221%20,expression%20of%20Rasa3%20and%20its">pmc.ncbi.nlm.nih.gov</a>). Such ideas are built on solid experimental evidence (e.g. CRISPR studies) and represent a <strong>new direction in immunotherapy research</strong>. At the same time, cancer biologists have pointed out the significance of RASA2 in tumors lacking direct Ras mutations. Since Ras itself is hard to target with drugs (aside from specific mutants like KRAS^G12C), <strong>restoring or mimicking RASA2 function</strong> could be a strategy to suppress Ras activity in tumors. However, reactivating a lost tumor suppressor is challenging ‚Äì thus, current research is more focused on understanding the pathways affected by RASA2 loss and finding synthetic lethal interactions. For instance, if a tumor loses RASA2, it might become particularly dependent on other signaling nodes that could be drugged. One study noted that RASA2 loss in melanoma often co-occurs with certain <strong>RAF or MEK pathway alterations</strong>, implying these tumors heavily rely on the MAPK cascade for growth (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4954601/#:~:text=Cutaneous%20melanoma%2C%20for%20which%20incidence,additional%20targetable%20alterations%20in%20melanoma">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4954601/#:~:text=We%20compiled%20somatic%20mutation%20data,of">pmc.ncbi.nlm.nih.gov</a>). This suggests that such tumors might respond well to MEK or ERK inhibitors, a hypothesis under investigation.</p>
<p>Structurally, ongoing research aims to <strong>resolve the three-dimensional structure of RASA2‚Äôs domains and their complexes with Ras</strong>, to better understand how exactly RASA2 engages Ras at membranes. While Ras‚ÄìGAP interactions have been visualized for other GAPs (like p120^RasGAP and neurofibromin) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=B%29%20RAS,through%20a%20distinct">pmc.ncbi.nlm.nih.gov</a>), RASA2 has unique regulatory domains whose conformational changes (perhaps upon binding PIP‚ÇÉ or Ca¬≤‚Å∫) are of great interest. Bioinformatic analyses show that RASA2 and its GAP1 family homologs are evolutionarily conserved in vertebrates and share significant homology, hinting that insights from one (e.g. RASA3‚Äôs interaction with phosphoinositides) can inform understanding of another. There is also interest in <strong>evolutionary biology of Ras GAPs</strong>: RASA2 might have arisen to provide fine-tuned control of Ras in specialized contexts (potentially relating to the immune system, given its prominent expression there). Comparative studies in mice have indicated that Rasa2 deficiency can enhance immune responses (as seen in T cell studies), and future work may create <strong>Rasa2-knockout animal models</strong> to observe any spontaneous disease or predisposition (e.g. cancer incidence or autoimmune phenotypes) arising from chronic Ras hyperactivity.</p>
<p>In summary, <strong>RASA2 is recognized as a key functional node in the Ras signaling network</strong>, coupling membrane second messengers to the termination of Ras activity. Its <strong>primary role</strong> is enzymatic: stimulating GTP hydrolysis on Ras to shut Ras off at the right time and place. Through this function, it safeguards cells from excessive Ras signaling, thereby influencing processes like proliferation, migration, and immune cell activation. The protein localizes to the cytosol and inner plasma membrane, guided by its PH and C2 domains, ensuring it acts in proximity to Ras. <strong>Disruption of RASA2 has tangible biological consequences</strong> ‚Äì from hyperactive T cells to aggressive tumor behavior ‚Äì underscoring why nature has conserved this Ras regulator. Current research (2023‚Äì2024) continues to unravel the nuances of RASA2‚Äôs regulation and to exploit its function in clinical applications, whether by targeting it in immunotherapy or considering its status in cancer treatment decisions. All evidence to date solidifies the view of RASA2 as an essential <strong>‚Äúoff-switch‚Äù for Ras, crucial for balanced signaling and normal cellular function</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12071082/#:~:text=The%20RAS%20signaling%20pathway%2C%20a,overactive%2C%20fueling%20cancer%20growth%20and">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12071082/#:~:text=,from%20general%20mechanisms%20and%20other">pmc.ncbi.nlm.nih.gov</a>).</p>
<p><strong>References:</strong> (Publication dates and sources are included in citations)</p>
<h2 id="citations">Citations</h2>
<ol>
<li>AnnotationURLCitation(end_index=445, start_index=284, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=RASA2%20and%20RASA3%2C%20which%20are,T%20cell%20activation%20and%20migration')</li>
<li>AnnotationURLCitation(end_index=706, start_index=558, title='RASA2 RAS p21 protein activator 2 [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene/5922#:~:text=Also%20known%20as%20GAP1M%20Summary,form%20of%20RAS%2C%20thereby%20allowing')</li>
<li>AnnotationURLCitation(end_index=1011, start_index=861, title='RASA2 RAS p21 protein activator 2 [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene/5922#:~:text=Summary%20The%20protein%20encoded%20by,provided%20by%20RefSeq%2C%20Dec%202014')</li>
<li>AnnotationURLCitation(end_index=1290, start_index=1140, title='RASA2 RAS p21 protein activator 2 [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene/5922#:~:text=Summary%20The%20protein%20encoded%20by,provided%20by%20RefSeq%2C%20Dec%202014')</li>
<li>AnnotationURLCitation(end_index=1608, start_index=1458, title='RASA2 RAS p21 protein activator 2 [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene/5922#:~:text=Summary%20The%20protein%20encoded%20by,provided%20by%20RefSeq%2C%20Dec%202014')</li>
<li>AnnotationURLCitation(end_index=2224, start_index=2063, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=domain%20structures%2C%20including%20GAP%20domains,The%20RASA3%20PH%20domain')</li>
<li>AnnotationURLCitation(end_index=2334, start_index=2225, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=A,through%20a%20distinct')</li>
<li>AnnotationURLCitation(end_index=2674, start_index=2513, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=domain%20structures%2C%20including%20GAP%20domains,The%20RASA3%20PH%20domain')</li>
<li>AnnotationURLCitation(end_index=3022, start_index=2895, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=which%20includes%20RASAL1%20,4%7D%29%20and')</li>
<li>AnnotationURLCitation(end_index=3383, start_index=3222, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=domain%20structures%2C%20including%20GAP%20domains,The%20RASA3%20PH%20domain')</li>
<li>AnnotationURLCitation(end_index=3685, start_index=3524, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=domain%20structures%2C%20including%20GAP%20domains,The%20RASA3%20PH%20domain')</li>
<li>AnnotationURLCitation(end_index=4245, start_index=4121, title='RASA2 RAS p21 protein activator 2 [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene/5922#:~:text=The%20protein%20encoded%20by%20this,9%29%20and%2024')</li>
<li>AnnotationURLCitation(end_index=4917, start_index=4799, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=B%29%20RAS,through%20a%20distinct')</li>
<li>AnnotationURLCitation(end_index=5184, start_index=5075, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=A,through%20a%20distinct')</li>
<li>AnnotationURLCitation(end_index=5512, start_index=5403, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=A,through%20a%20distinct')</li>
<li>AnnotationURLCitation(end_index=6090, start_index=5940, title='RASA2 RAS p21 protein activator 2 [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene/5922#:~:text=Summary%20The%20protein%20encoded%20by,provided%20by%20RefSeq%2C%20Dec%202014')</li>
<li>AnnotationURLCitation(end_index=6310, start_index=6180, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=Several%20RAS,specific%20GAPs%20%5B%2041%2C54')</li>
<li>AnnotationURLCitation(end_index=6619, start_index=6458, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=RASA2%20and%20RASA3%2C%20which%20are,T%20cell%20activation%20and%20migration')</li>
<li>AnnotationURLCitation(end_index=7832, start_index=7705, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=which%20includes%20RASAL1%20,4%7D%29%20and')</li>
<li>AnnotationURLCitation(end_index=8274, start_index=8106, title='A Systematic Analysis of Expression and Function of RAS GTPase-Activating Proteins (RASGAPs) in Urological Cancers: A Mini-Review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12071082/#:~:text=%5B104%5D.%20Furthermore%2C%20loss,the%20Ras%20signaling%20pathway%2C%20potentially')</li>
<li>AnnotationURLCitation(end_index=8744, start_index=8617, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=Repeats,these%20GAPs%2C%20how%20they%20are')</li>
<li>AnnotationURLCitation(end_index=8841, start_index=8745, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=,Figure%201')</li>
<li>AnnotationURLCitation(end_index=9038, start_index=8894, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L349%20,in%20T%20cells%20remained%20unexplored')</li>
<li>AnnotationURLCitation(end_index=9488, start_index=9368, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L356%20Figure%202A,TCR')</li>
<li>AnnotationURLCitation(end_index=9830, start_index=9704, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L360%20antibodies%20in,2%2C3')</li>
<li>AnnotationURLCitation(end_index=10190, start_index=10020, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L373%20succinimidyl%20ester,reg%7D%20cells%20%5B2%2C3%5D.%20Cells%20were')</li>
<li>AnnotationURLCitation(end_index=10488, start_index=10361, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=Repeats,these%20GAPs%2C%20how%20they%20are')</li>
<li>AnnotationURLCitation(end_index=11426, start_index=11265, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=RASA2%20was%20identified%20as%20an,defects%20and%20elevated%20RAS%20activity')</li>
<li>AnnotationURLCitation(end_index=11851, start_index=11690, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=RASA2%20was%20identified%20as%20an,defects%20and%20elevated%20RAS%20activity')</li>
<li>AnnotationURLCitation(end_index=12531, start_index=12404, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=which%20includes%20RASAL1%20,4%7D%29%20and')</li>
<li>AnnotationURLCitation(end_index=13267, start_index=13140, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=which%20includes%20RASAL1%20,4%7D%29%20and')</li>
<li>AnnotationURLCitation(end_index=13991, start_index=13830, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=domain%20structures%2C%20including%20GAP%20domains,The%20RASA3%20PH%20domain')</li>
<li>AnnotationURLCitation(end_index=14939, start_index=14797, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=affinity%20for%20PI%283%2C4%2C5%29P_,2%7D%20%5B%2050%2C32')</li>
<li>AnnotationURLCitation(end_index=15204, start_index=15070, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=which%20includes%20RASAL1%20,2%7D%20%5B%2050%2C32')</li>
<li>AnnotationURLCitation(end_index=16077, start_index=15910, title='A Systematic Analysis of Expression and Function of RAS GTPase-Activating Proteins (RASGAPs) in Urological Cancers: A Mini-Review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12071082/#:~:text=Mutations%20in%20RASGAPs%20also%20play,of%20RASGAPs%20promote%20tumorigenesis%20by')</li>
<li>AnnotationURLCitation(end_index=16383, start_index=16216, title='A Systematic Analysis of Expression and Function of RAS GTPase-Activating Proteins (RASGAPs) in Urological Cancers: A Mini-Review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12071082/#:~:text=Mutations%20in%20RASGAPs%20also%20play,of%20RASGAPs%20promote%20tumorigenesis%20by')</li>
<li>AnnotationURLCitation(end_index=16649, start_index=16482, title='A Systematic Analysis of Expression and Function of RAS GTPase-Activating Proteins (RASGAPs) in Urological Cancers: A Mini-Review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12071082/#:~:text=Mutations%20in%20RASGAPs%20also%20play,of%20RASGAPs%20promote%20tumorigenesis%20by')</li>
<li>AnnotationURLCitation(end_index=17762, start_index=17609, title='Recurrent inactivating RASA2 mutations in melanoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4954601/#:~:text=Analysis%20of%20501%20melanoma%20exomes,of%20Ras%20GAPs%20in%20cancer')</li>
<li>AnnotationURLCitation(end_index=18027, start_index=17861, title='Recurrent inactivating RASA2 mutations in melanoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4954601/#:~:text=mutations%20encompass%20at%20least%2020,the%20CytoScan%20High%20Definition%20array')</li>
<li>AnnotationURLCitation(end_index=18353, start_index=18200, title='Recurrent inactivating RASA2 mutations in melanoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4954601/#:~:text=Analysis%20of%20501%20melanoma%20exomes,of%20Ras%20GAPs%20in%20cancer')</li>
<li>AnnotationURLCitation(end_index=18658, start_index=18505, title='Recurrent inactivating RASA2 mutations in melanoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4954601/#:~:text=Analysis%20of%20501%20melanoma%20exomes,of%20Ras%20GAPs%20in%20cancer')</li>
<li>AnnotationURLCitation(end_index=19028, start_index=18875, title='Recurrent inactivating RASA2 mutations in melanoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4954601/#:~:text=Analysis%20of%20501%20melanoma%20exomes,of%20Ras%20GAPs%20in%20cancer')</li>
<li>AnnotationURLCitation(end_index=19355, start_index=19198, title='Recurrent inactivating RASA2 mutations in melanoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4954601/#:~:text=Analysis%20of%20501%20melanoma%20exomes,importance%20of%20Ras%20GAPs%20in')</li>
<li>AnnotationURLCitation(end_index=19948, start_index=19781, title='A Systematic Analysis of Expression and Function of RAS GTPase-Activating Proteins (RASGAPs) in Urological Cancers: A Mini-Review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12071082/#:~:text=Mutations%20in%20RASGAPs%20also%20play,of%20RASGAPs%20promote%20tumorigenesis%20by')</li>
<li>AnnotationURLCitation(end_index=20118, start_index=19949, title='A Systematic Analysis of Expression and Function of RAS GTPase-Activating Proteins (RASGAPs) in Urological Cancers: A Mini-Review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12071082/#:~:text=cell%20lung%20cancer%20,pathological%20implications%20in%20urological%20malignancies')</li>
<li>AnnotationURLCitation(end_index=20992, start_index=20831, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=RASA2%20was%20identified%20as%20an,defects%20and%20elevated%20RAS%20activity')</li>
<li>AnnotationURLCitation(end_index=21245, start_index=21122, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=%2A%2039.Chen%20P,PMC%20free%20article')</li>
<li>AnnotationURLCitation(end_index=22771, start_index=22651, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L356%20Figure%202A,TCR')</li>
<li>AnnotationURLCitation(end_index=22898, start_index=22772, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L360%20antibodies%20in,2%2C3')</li>
<li>AnnotationURLCitation(end_index=23240, start_index=23116, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=,cells%20during%20exhaustion%20and%20in')</li>
<li>AnnotationURLCitation(end_index=23545, start_index=23421, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=,cells%20during%20exhaustion%20and%20in')</li>
<li>AnnotationURLCitation(end_index=23700, start_index=23546, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L215%20adoptive%20cell,T%20cell%20responses%20in%20mouse')</li>
<li>AnnotationURLCitation(end_index=24074, start_index=23930, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L211%20,cells%20during%20exhaustion%20and%20in')</li>
<li>AnnotationURLCitation(end_index=24448, start_index=24304, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L211%20,cells%20during%20exhaustion%20and%20in')</li>
<li>AnnotationURLCitation(end_index=24856, start_index=24702, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L215%20adoptive%20cell,T%20cell%20responses%20in%20mouse')</li>
<li>AnnotationURLCitation(end_index=25193, start_index=25069, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=,cells%20during%20exhaustion%20and%20in')</li>
<li>AnnotationURLCitation(end_index=26139, start_index=25961, title='Genome-wide CRISPR/Cas9 screens reveal shared and cell-specific mechanisms of resistance to SHP2 inhibition - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9998968/#:~:text=To%20identify%20SHP2i%20resistance%20mechanisms%2C,sensitization%20to%20SHP2i%20required%20its')</li>
<li>AnnotationURLCitation(end_index=26464, start_index=26286, title='Genome-wide CRISPR/Cas9 screens reveal shared and cell-specific mechanisms of resistance to SHP2 inhibition - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9998968/#:~:text=To%20identify%20SHP2i%20resistance%20mechanisms%2C,sensitization%20to%20SHP2i%20required%20its')</li>
<li>AnnotationURLCitation(end_index=27724, start_index=27563, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=RASA2%20and%20RASA3%2C%20which%20are,T%20cell%20activation%20and%20migration')</li>
<li>AnnotationURLCitation(end_index=27852, start_index=27725, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=Repeats,these%20GAPs%2C%20how%20they%20are')</li>
<li>AnnotationURLCitation(end_index=28200, start_index=28073, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=Repeats,these%20GAPs%2C%20how%20they%20are')</li>
<li>AnnotationURLCitation(end_index=28559, start_index=28436, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=,T%20cell%20dysfunction%20in%20disease')</li>
<li>AnnotationURLCitation(end_index=28701, start_index=28560, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=match%20at%20L221%20,expression%20of%20Rasa3%20and%20its')</li>
<li>AnnotationURLCitation(end_index=29832, start_index=29645, title='Recurrent inactivating RASA2 mutations in melanoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4954601/#:~:text=Cutaneous%20melanoma%2C%20for%20which%20incidence,additional%20targetable%20alterations%20in%20melanoma')</li>
<li>AnnotationURLCitation(end_index=29961, start_index=29833, title='Recurrent inactivating RASA2 mutations in melanoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4954601/#:~:text=We%20compiled%20somatic%20mutation%20data,of')</li>
<li>AnnotationURLCitation(end_index=30489, start_index=30371, title='Mind the GAP: RASA2 and RASA3 GTPase Activating Proteins as gatekeepers of T cell activation and adhesion - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10621891/#:~:text=B%29%20RAS,through%20a%20distinct')</li>
<li>AnnotationURLCitation(end_index=32745, start_index=32574, title='A Systematic Analysis of Expression and Function of RAS GTPase-Activating Proteins (RASGAPs) in Urological Cancers: A Mini-Review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12071082/#:~:text=The%20RAS%20signaling%20pathway%2C%20a,overactive%2C%20fueling%20cancer%20growth%20and')</li>
<li>AnnotationURLCitation(end_index=32873, start_index=32746, title='A Systematic Analysis of Expression and Function of RAS GTPase-Activating Proteins (RASGAPs) in Urological Cancers: A Mini-Review - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12071082/#:~:text=,from%20general%20mechanisms%20and%20other')</li>
</ol>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">üìÑ View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: Q15283
gene_symbol: RASA2
product_type: PROTEIN
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: &#39;RAS p21 protein activator 2, GTPase-activating protein (GAP) for RAS family small GTPases.
  Member of GAP1 family of RasGAPs characterized by tandem C2 domains (Ca2+ and phospholipid binding),
  pleckstrin homology (PH) domain (binds PIP3 with high affinity), and C-terminal RasGAP catalytic domain.
  Functions as tumor suppressor by negatively regulating RAS signaling: catalyzes GTP hydrolysis on RAS
  proteins (HRAS, KRAS, NRAS, R-Ras) via arginine-finger mechanism (Arg-511), converting active RAS-GTP
  to inactive RAS-GDP. Cytoplasmic protein with regulated membrane association - PH domain recruitment
  to PIP3-enriched membranes brings RASA2 to sites of active RAS signaling. Loss of RASA2 leads to hyperactive
  RAS-MAPK and RAS-PI3K pathways, promoting cell proliferation, survival, and tumorigenesis. Recurrent
  inactivating mutations identified in ~5% of melanomas; loss associated with enhanced ERK signaling,
  increased proliferation/migration, and worse patient outcomes. Rare germline mutations cause Noonan
  syndrome (Rasopathy) due to elevated developmental RAS activity. In T cells, RASA2 acts as brake on
  TCR signaling - RASA2-deficient T cells show ~2-fold increased proliferation, enhanced activation markers
  (CD69, CD154), heightened antigen sensitivity, and improved tumor cell killing. Expression in immune
  cells, endothelium, and various tissues. Part of negative feedback mechanisms restraining growth factor
  receptor signaling cascades.&#39;
existing_annotations:
- term:
    id: GO:0005096
    label: GTPase activator activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: RASA2/GAP1m is a Ras GTPase-activating protein that accelerates hydrolysis of Ras-GTP to
      Ras-GDP, thereby downregulating RAS output. This is the core molecular function of the protein,
      supported by phylogenetic inference and extensive literature.
    action: ACCEPT
    reason: Core enzymatic function of RASA2. The protein contains a conserved RasGAP catalytic domain
      with an arginine finger residue (Arg-397 in human) that is essential for stimulating GTP hydrolysis.
      This function is well-established across the GAP1 family of RasGAPs.
    supported_by:
    - reference_id: PMID:8812506
      supporting_text: We have previously isolated a novel Ras GTPase-activating protein (Ras GAP), Gap1m,
        from rat brain. Gap1m is considered to be a negative regulator of the Ras signaling pathways,
        like other Ras GAPs, neurofibromin, which is a gene product of the neurofibromatosis type I gene,
        and p120GAP.
    - reference_id: Reactome:R-HSA-5658435
      supporting_text: GAP proteins stimulate RAS GTPase activity by inserting a conserved arginine residue
        into the RAS active site, promoting a conformational change in the active site to allow GTP hydrolysis
        (Ahamdian et al, 2003; Scheffzek et al, 1997; Ahamdian et al, 1997).
    - reference_id: file:human/RASA2/RASA2-deep-research-openai.md
      supporting_text: See deep research file for comprehensive analysis
- term:
    id: GO:1902531
    label: regulation of intracellular signal transduction
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: RASA2 regulates intracellular signal transduction by negatively regulating the RAS-RAF-MEK-ERK
      cascade and RAS-PI3K signaling. Loss of RASA2 leads to hyperactive MAPK signaling.
    action: ACCEPT
    reason: Core regulatory function. RASA2 functions as an intracellular checkpoint that limits RAS/MAPK
      signaling. In T cells, RASA2 deficiency results in enhanced MAPK signaling and increased T cell
      activation.
    supported_by:
    - reference_id: file:human/RASA2/RASA2-deep-research-falcon.md
      supporting_text: RASA2 negatively regulates the RAS-RAF-MEK-ERK cascade by accelerating Ras GTP
        hydrolysis; its lipid-binding domains coordinate membrane recruitment, ensuring spatial coupling
        of Ras inactivation with effector engagement.
- term:
    id: GO:0005096
    label: GTPase activator activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: Automated annotation of GTPase activator activity based on combined computational evidence.
      Consistent with the experimentally validated RasGAP function of RASA2.
    action: ACCEPT
    reason: Core enzymatic function. Duplicates the IBA annotation with computational evidence, which
      is consistent with the known function.
    supported_by:
    - reference_id: file:human/RASA2/RASA2-uniprot.txt
      supporting_text: Inhibitory regulator of the Ras-cyclic AMP pathway.
- term:
    id: GO:0005543
    label: phospholipid binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: RASA2 contains PH and C2 domains that bind membrane phospholipids. The PH domain binds PIP3
      with high affinity, and the tandem C2 domains bind calcium and phospholipids for membrane targeting.
    action: ACCEPT
    reason: Important accessory function for membrane localization. The PH domain enables recruitment
      to PIP3-enriched membranes where active RAS signaling occurs. The C2 domains provide additional
      lipid-binding capacity.
    supported_by:
    - reference_id: file:human/RASA2/RASA2-deep-research-falcon.md
      supporting_text: PH and C2 domains confer lipid-dependent membrane association of RasGAPs, coordinating
        with the catalytic domain to accelerate Ras GTP hydrolysis at the plasma membrane/inner leaflet
        signalling sites.
    - reference_id: file:human/RASA2/RASA2-uniprot.txt
      supporting_text: Binds inositol tetrakisphosphate (IP4).
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: RASA2 is a cytoplasmic protein with regulated membrane association. It is recruited to the
      plasma membrane via PH domain binding to PIP3 upon growth factor stimulation.
    action: ACCEPT
    reason: Core localization. UniProt explicitly states cytoplasmic localization. The cytoplasmic pool
      is recruited to membranes in response to signaling.
    supported_by:
    - reference_id: file:human/RASA2/RASA2-uniprot.txt
      supporting_text: &#39;SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, perinuclear region.&#39;
- term:
    id: GO:0008270
    label: zinc ion binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: RASA2 contains a Btk-type zinc finger domain (residues 708-744) with four conserved cysteine
      residues (Cys-716, Cys-727, Cys-728, Cys-738) that coordinate a zinc ion.
    action: ACCEPT
    reason: Structural requirement for protein stability. The Btk-type zinc finger is a conserved structural
      element in the GAP1 family.
    supported_by:
    - reference_id: file:human/RASA2/RASA2-uniprot.txt
      supporting_text: ZN_FING 708..744 /note=&#34;Btk-type&#34;
- term:
    id: GO:0035556
    label: intracellular signal transduction
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: RASA2 participates in intracellular signal transduction as a negative regulator of RAS signaling
      pathways, including RAS-MAPK and RAS-PI3K cascades.
    action: ACCEPT
    reason: Core function in signal transduction. RASA2 terminates RAS signaling by catalyzing GTP hydrolysis,
      which is a fundamental intracellular signaling mechanism.
    supported_by:
    - reference_id: PMID:8699317
      supporting_text: Ras, ras gene product, is a GTP binding protein which controls the signal transduction
        by GTP hydrolysis.
- term:
    id: GO:0046580
    label: negative regulation of Ras protein signal transduction
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: RASA2 is a bona fide negative regulator of Ras signaling, converting active RAS-GTP to inactive
      RAS-GDP. This is the primary biological function of the protein.
    action: ACCEPT
    reason: Core biological process. This term accurately captures the primary regulatory role of RASA2
      in attenuating RAS signaling cascades.
    supported_by:
    - reference_id: PMID:8812506
      supporting_text: Gap1m is considered to be a negative regulator of the Ras signaling pathways, like
        other Ras GAPs, neurofibromin, which is a gene product of the neurofibromatosis type I gene, and
        p120GAP.
    - reference_id: Reactome:R-HSA-5658435
      supporting_text: The human genome encodes at least 10 proteins that bind RAS and activate its intrinsic
        GTPase activity, resulting in the formation of inactive RAS:GDP and attenuating RAS signaling
        (reviewed in King et al, 2013).
- term:
    id: GO:0046872
    label: metal ion binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: RASA2 binds zinc ions via its Btk-type zinc finger domain. This is a more general term than
      GO:0008270 (zinc ion binding).
    action: KEEP_AS_NON_CORE
    reason: Redundant with the more specific zinc ion binding annotation. The metal ion binding is structural
      rather than catalytic.
    supported_by:
    - reference_id: file:human/RASA2/RASA2-uniprot.txt
      supporting_text: ZN_FING 708..744 /note=&#34;Btk-type&#34; with BINDING sites for Zn(2+) at residues 716,
        727, 728, 738.
- term:
    id: GO:0048471
    label: perinuclear region of cytoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: RASA2 localizes to the perinuclear region of the cytoplasm according to UniProt annotation.
    action: KEEP_AS_NON_CORE
    reason: This represents a specific sublocalization within the cytoplasm. While valid, this may represent
      a steady-state localization rather than the functional site (plasma membrane upon recruitment).
    supported_by:
    - reference_id: file:human/RASA2/RASA2-uniprot.txt
      supporting_text: &#39;SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, perinuclear region.&#39;
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  review:
    summary: RASA2 was identified in protein interaction studies (BioPlex 3.0). The term protein binding
      is uninformative as it does not specify the binding partner or functional consequence.
    action: MODIFY
    reason: Protein binding is too generic. RASA2 specifically binds RAS proteins (its substrates), and
      has been shown to interact with NOLC1 and potentially p53. A more informative term would be GTPase
      binding or Ras GTPase binding.
    proposed_replacement_terms:
    - id: GO:0017016
      label: Ras GTPase binding
    supported_by:
    - reference_id: PMID:33961781
      supporting_text: Through affinity-purification mass spectrometry, we have created two proteome-scale,
        cell-line-specific interaction networks.
    - reference_id: file:human/RASA2/RASA2-uniprot.txt
      supporting_text: &#39;Q15283; Q14978: NOLC1; NbExp=2&#39;
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5658231
  review:
    summary: RASA2 is localized in the cytosol and is recruited to membranes to stimulate RAS GTPase activity.
      Reactome pathway includes RASA2 as a cytosolic GAP.
    action: ACCEPT
    reason: Consistent with UniProt annotation of cytoplasmic localization. The cytosol represents the
      soluble pool of RASA2 before membrane recruitment.
    supported_by:
    - reference_id: Reactome:R-HSA-5658231
      supporting_text: The intrinsic GTPase activity of RAS proteins is stimulated by the GAP proteins,
        of which there are at least 10 in the human genome (reviewed in King et al, 2013).
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5658435
  review:
    summary: Duplicate cytosol annotation from Reactome pathway describing RAS GAP binding to RAS-GTP.
    action: ACCEPT
    reason: Consistent localization annotation. RASA2 is a cytosolic protein that is recruited to membranes
      where RAS is tethered.
    supported_by:
    - reference_id: Reactome:R-HSA-5658435
      supporting_text: These identified RAS GAP proteins are RASA1 (also known as p120 GAP), NF1, the
        GAP1 family (RASA2, RASA3, RASA4 and RASAL1) and the SYNGAP family (SYNGAP1, DAB2IP, RASAL2 and
        RASAL3).
- term:
    id: GO:0005096
    label: GTPase activator activity
  evidence_type: TAS
  original_reference_id: PMID:8812506
  review:
    summary: Original cloning paper for human GAP1M/RASA2 establishing it as a novel Ras GTPase-activating
      protein distinct from p120GAP and NF1.
    action: ACCEPT
    reason: Core enzymatic function established in the original characterization of human RASA2. The paper
      identifies GAP1M as a novel Ras GAP.
    supported_by:
    - reference_id: PMID:8812506
      supporting_text: We have previously isolated a novel Ras GTPase-activating protein (Ras GAP), Gap1m,
        from rat brain.
- term:
    id: GO:0007165
    label: signal transduction
  evidence_type: TAS
  original_reference_id: PMID:8699317
  review:
    summary: Review paper describing the heterogeneity of Ras GAPs and their roles in regulating Ras signal
      transduction, including Gap1m (RASA2).
    action: ACCEPT
    reason: RASA2 participates in signal transduction by negatively regulating the Ras signaling pathway.
      This is a general but accurate process annotation.
    supported_by:
    - reference_id: PMID:8699317
      supporting_text: The proto-oncogene ras is an essential gene for the growth and the differentiation
        for various types of cells. Ras, ras gene product, is a GTP binding protein which controls the
        signal transduction by GTP hydrolysis.
- term:
    id: GO:0007165
    label: signal transduction
  evidence_type: TAS
  original_reference_id: PMID:8812506
  review:
    summary: Duplicate signal transduction annotation based on the original cloning paper.
    action: ACCEPT
    reason: Valid annotation. RASA2 functions in signal transduction as a negative regulator of the Ras
      pathway.
    supported_by:
    - reference_id: PMID:8812506
      supporting_text: Gap1m is considered to be a negative regulator of the Ras signaling pathways, like
        other Ras GAPs, neurofibromin, which is a gene product of the neurofibromatosis type I gene, and
        p120GAP.
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO terms.
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping,
    accompanied by conservative changes to GO terms applied by UniProt.
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods.
  findings: []
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
  findings: []
- id: PMID:8699317
  title: &#39;[Heterogeneity of GTPase-activating proteins for Ras in the regulation of Ras signal transduction
    pathway].&#39;
  findings: []
- id: PMID:8812506
  title: cDNA cloning and chromosomal mapping of a novel human GAP (GAP1M), a GTPase-activating protein
    of Ras.
  findings: []
- id: Reactome:R-HSA-5658231
  title: RAS GAPs stimulate RAS GTPase activity
  findings: []
- id: Reactome:R-HSA-5658435
  title: RAS GAPs bind RAS:GTP
  findings: []
- id: file:human/RASA2/RASA2-deep-research-openai.md
  title: Deep research on RASA2 function
  findings: []
aliases:
- RAS p21 protein activator 2
- GAP1(m)
- GAP1 family member 2
core_functions:
- molecular_function:
    id: GO:0005096
    label: GTPase activator activity
  description: RasGAP that catalyzes GTP hydrolysis on RAS proteins (HRAS, KRAS, NRAS, R-Ras), converting
    active RAS-GTP to inactive RAS-GDP. Negatively regulates RAS-MAPK and RAS-PI3K signaling. Functions
    as tumor suppressor. PH domain binds PIP3 for membrane recruitment to sites of RAS activation.
  locations:
  - id: GO:0005737
    label: cytoplasm
  - id: GO:0005829
    label: cytosol
  directly_involved_in:
  - id: GO:0046580
    label: negative regulation of Ras protein signal transduction
  - id: GO:1902531
    label: regulation of intracellular signal transduction
  supported_by:
  - reference_id: file:human/RASA2/RASA2-uniprot.txt
    supporting_text: Inhibitory regulator of the Ras-cyclic AMP pathway.
  - reference_id: PMID:8812506
    supporting_text: We have previously isolated a novel Ras GTPase-activating protein (Ras GAP), Gap1m,
      from rat brain.
status: COMPLETE
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>